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ABSTRACT
Mapping of the Rotavirus Nonstructural Protein-4-Caveolin-1 Binding Site
to Three Hydrophobic Residues Within the Extended, C-Terminal
Amphipathic Alpha Helix. (December 2008)
Cecelia Victoria Williams, B.A., University of New Mexico;
M.S., University of New Mexico; M.S. University of New Mexico
Chair of Advisory Committee: Dr. Judith M. Ball
Rotavirus NSP4, the first described viral enterotoxin, localizes to the plasma
membrane of infected cells, possibly through interaction with caveolin-1. A direct
interaction between NSP4 and caveolin-1, the structural protein of caveolae, was shown
by yeast two-hybrid, peptide binding, and FRET analyses. To dissect the precise NSP4
binding domain to caveolin-1, mutants were prepared by altering either the charged or
hydrophobic face of the NSP4 C-terminal amphipathic alpha-helix and examined for
binding to caveolin-1. Replacing six charged residues with alanine (FLNSP4Ala)
disrupted the charged face, while the hydrophobic face was disrupted by replacing
selected hydrophobic residues with charged amino acids (aa) (FLNSP4HydroMut). In yeast
two-hybrid and peptide binding assays, FLNSP4Ala retained its binding capacity,
whereas FLNSP4HydroMut failed to bind caveolin-1. Mutants were generated with an N-
terminal truncated clone (NSP446-175), which removed the hydrophobic domains and
aided in yeast-two hybrid assays. These mutants exhibited the same binding pattern as
iv
FLNSP4 confirming that the N-terminus of NSP4 lacks the caveolin-1 binding site and
NSP446-175 is sufficient for binding.
Seven additional mutants were prepared from NSP4HydroMut in which individually
charged residues were reverted to the original hydrophobic aa or were replaced with
alanine. Analyses of the interaction of these revertants with caveolin-1 localized the
NSP4 binding domain to one critical hydrophobic aa (L116) and one or two additional
aa (I113, L127, and/or L134) on the hydrophobic face. Those mutants that bound
caveolin-1 bound both the N- and C-terminal caveolin-1 peptides, but lacked binding to
a centrally located peptide. These data suggest conformational and hydrophobic
constraints play a role in the NSP4-caveolin-1 association.
The mutant NSP4 molecules also were evaluated for transport to the plasma
membrane. Mammalian cells were transfected with FLNSP4, FLNSP41-175Ala, and
NSP41-175HydroMut plasmid DNA, surface biotinylated, and examined by IFA or Western
blot for NSP4 expression. Epifluorescence revealed FLNSP4 and FLNSP4Ala were
exposed on the cell surface in the absence of other viral proteins, whereas NSP4HydroMut
remained intracellular. Further, NSP4-transfected cells displayed an intracellular
association of with caveolin-1 or the caveolin-1 chaperone complex proteins. These data
indicate NSP4 interacts with caveolin-1 in the absence of other viral proteins.
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NOMENCLATURE
aa amino acid
AAH amphipathic alpha helical
-gal -galactosidase
BGU -galactosidase units
BHK-21 Baby hamster kidney cells
bp base pairs
BM basement membrane
[Ca+2]i intracellular calcium
cav caveolin
CCC Caveolin 1 chaperone complex
CCD coiled coil domain
CHO clycosylation sites
Cl- chloride
CSC cavitation-sucrose chromatography
CSD Caveolin scaffolding domain
C-MAD C-terminal membrane attachment domain
DGE Aspartate-glycine-glutamate
DLP Double-layered particle
ds RNA Double stranded RNA
EGFP Enhanced green fluorescent protein
eIF eukaryotic initiation factor
viii
ER endoplasmic reticulum
endo H Endo--N-acetylglucosaminidase H
ERCIC Endoplasmic reticulum Golgi intermediate complex
FL full lengh
FRET Fluorescent resonance energy transfer
H Hydrophobic domain
HDL high density lipoproteins
hpi hours post infection
hpt hours post transfection
hsp Heat shock protein
IDV I Integrated density value
IFA Indirect fluorescence antibody
IP3 Inositol 1,4,5-triphosphate
kDa kilodalton
MOI Multiplicity of infection
MDCK Madin-Darby canine kidney cells
Mmol millimole
mRNA messenger RNA
NSP, NSP4 Nonstructural protein; Nonstructural protein 4
NA Neuraminidase
N-MAD N-terminal membrane attachment domain
OD600 optical density
ix
PAPB Poly (A)-binding protein
PIP2 Phosphatidylinositol 4,5 bisphosphate
PLC Phospholipase C
PM Plasma membrane
PMSF Phenylmethysulfonyl fluoride
Poly (A) Polyadenylation
RT room temperature
RV Rotavirus
SA sialic acid
SLP Single-layered particle
TLP Triple-layered particle
VP viral protein
USAF United States Air Force
Y2H Yeast two-hybrid
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1CHAPTER I
INTRODUCTION: ROTAVIRUS, NONSTRUCTURAL PROTEIN-4,
CAVEOLIN-1, AND THEIR INTERACTION
Rotavirus Infection
Interest in rotavirus (RV) has grown over the past 30 years, since its first
discovery as a major etiologic agent of viral gastroenteritis and diarrhea in young
children and mammals (Ball et al., 2005; Dupuis et al., 1995; Estes, 2001; Marrie et al.,
1982; Mattion et al., 1994; Parashar et al., 2003; Ramig, 1997). Also, RV has been
shown to cause viral gastroenteritis and diarrhea in the elderly and immune-
compromised adults (Dupuis et al., 1995; Marrie et al., 1982). RV is the number one,
worldwide cause of viral diarrhea in infants and young children under the age of five
years (Widdowson et al., 2005) causing severe dehydration that frequently results in
death. Annually, 111 million cases of RV infection occur worldwide, with
approximately 25 million clinical visits, 2 million hospitalizations and by some
estimates, up to 1 million deaths (Parashar et al., 2003). Infant deaths in developing
countries account for about 82% of the RVassociated deaths (Ramig, 2004). The
occurrence rate of RV infection in developed countries, such as the United States, is
about 1% of that of the developing countries with a death rate of 0.02 %. However, the
economic impact upon the United States’ health care system is upwards to a billion
dollars (Glass et al., 1996).
_______________
The style of this dissertation follows that of Virology.
2RV infects mature enterocytes lining the intestinal villi suggesting these cells
have a RV-sensitive receptor as well as a cellular environment favorable to RV infection
(Ramig, 2004). The early stage of RV infection is typified by diarrhea prior to the
detection of histologic lesions with minimal inflammation (Ramig, 2004). RV-induced
gastroenteritis has been shown to cause intestinal damage including flattening of villi
and deepening of crypts (Davidson et al., 1977) that results in malabsorption. Early
diarrhea results from release of NSP4 by a non-classical pathway that initiates the
release of [Ca++] from the endoplasmic reticulum (ER) increasing [Ca++]i. NSP4 disrupts
tight junctions allowing paracellular flow of water and electrolytes. Extracellular NSP4
appears to bind a specific receptor on the same or an uninfected cell triggering a
signaling cascade via phospholipase C (PLC) and inositol 1,4,5-triphosphate (IP3) that
stimulating mobilization of [Ca++]I and chloride (Cl-) secretion. The elevated [Ca++]I
levels disrupt the microvilli cytoskeleton network, decrease expression of disaccharides
and enzymes at the apical surfaces, and inhibits sodium (Na+) solute cotransport (Dong
et al., 1997). NSP4 also plays a role in the secretory component of RV infection that is
characterized by transepithelial Cl- secretion and paracellular movement of Na+ and
water into the intestinal lumen (Morris et al., 1999).
Serogroup A RV causes the most common type of RV enteric disease. Four other
serogroups, B-E, are currently recognized; these are collectively known as the non-group
A RV, with groups B and C also infecting humans (Mattion et al., 1994; Ramig, 2004).
These non-group A RV have been associated with major epidemics of diarrhea in adults
in China and India (Fang et al., 1989; Krishnan et al., 1999), suggesting the possible
3emergence of new human pathogens. Many mammal RVs are potentially cross-
transmissible between man and mammals. Since RV infection occurs in a large variety
of mammal species, it has been suggested that some of the non-group A RV may have
been derived from swine and cattle through agriculture ground water cross
contamination (Desselberger et al., 2001).
Rotavirus Morphology
RV belong to the Reoviridae, Respiratory and Enteric Orphan, family of double
stranded RNA (dsRNA) viruses (Ramig, 1997). These virions are non-enveloped with
icosahedral capsid symmetry, 75-100 nm in size, and a segmented genome (Estes, 2001;
Ramig, 1994). The RV structure is a triple-layered capsid surrounding an inner protein
core containing the genome. The genome consists of 11 double-stranded segments. Ten
of these gene segments uniquely encode six structural viral proteins (VP) and four
nonstructural proteins (NSP), while the eleventh segment encodes two NSP proteins
(Estes et al., 2001; Mattion et al., 1994; Ramig, 1994). Each RNA segment contains a 5’
cap structure; however, they do not contain polyadenylation (poly A) tails (Jayaram et
al., 2004). Figure 1.1A depicts the RV triple-layered particle with cut-aways showing the
internal arrangement of the viral proteins and 1.1B shows a Western blot of the structural
and nonstructural proteins of a simian RV indicating the relationship to the RNA
transcripts.
The inner capsid is made up of VP2 and forms the single layer particle (SLP) that
contains the dsRNA genome. The SLP contains the transcription enzymes, VP1 and
VP3, required for the synthesis of mRNA transcripts (Chwetzoff and Trugnan, 2006;
4Estes et al., 2001) and serves as the metabolically active macromolecular machine from
which the mRNAs are transcribed (Coombs, 2006). VP1 is a RNA-dependant RNA
polymerase that function in the production of messenger RNAs (mRNAs) from the
minus strand genomic templates (Valenzuela et al., 1991), while VP3 possesses
guanylyl- and methyltranferase activity which supplies the 5’ cap structure to the both
the mRNAs and the plus strand genome segments (Pizarro et al., 1991).
A. B.
Figure 1.1. A. Cryo-EM reconstruction of the rotavirus triple-layer particle. The two outer shells are
arranged on a T = 13l (levo) icosahedral lattice. VP-7, the major component of outer capsid, is shown in
yellow. VP-4 (orange) occurs as 60 surface spikes protruding ~120 Å from the capsid surface. VP-6 is the
second shell trimer protein (blue) and VP-2 is the inner core protein (green). VP1/3, the transcription
enzymes, are located in the inner core (red). The genome segments (RNA) are shown as inverted conical
spirals surrounding the transcription enzymes (Jayaram et al., 2004). B. Rotavirus western blot. Western
blot showing the structural and nonstructural proteins of a Simian rotavirus indicating relationship to the
RNA transcripts (Scott et al., 2005).
Both the intermediate and outer capsid possess T =13 icosahedral symmetry. The
intermediate capsid is formed by VP6 trimers located below VP7. VP6 functions in the
organization of the RV through interactions with the outer layer protein (VP7) and VP2,
5the inner most layer protein, thus integrating the cell entry and endogenous transcription
functions (Pesavento et al., 2006). The transcriptionally active DLP has a VP6 coat. The
outer capsid of the triple-layered particle (TLP) is composed of VP7, a surface
glycoprotein, and VP4, the spike protein, both of which interact with neutralizing
antibodies (Estes, 2001; Ramig, 1997). Dimers of VP4 make up the spikes protruding
from the outer capsid. VP4 is multi-functional, playing roles in hemagglutination,
neutralization, entry into the cell, virulence, and pathogenicity (Delmas et al., 2004).
VP4 interacts with not only VP7, but also with VP6, spanning both layers (Estes, 2001).
The RV structure is distinctive in that it possesses 132 large channels that
penetrate through the VP6 and VP7 layers that serve to pass aqueous materials and
biochemical substances in and out of the inner capsid (Pasavento et al., 2006).
Additionally, during transcription RV use the type I channels to discharge the viral
mRNA from the subviral particles to the cytosol of the cell (Lawton et al., 2000). The
channels are located at the quasi six-fold and five-fold axes of the t = 13 lattice, type I
channels (12 each) are located at the five-fold vertices, type II channels (60 each) occur
at the pentavalent sites surrounding the type I channels, and type III channels (60 each)
are located at the hexavalent positions surrounding the three-fold axes (Pasavento et al.,
2006).
The RV non-structural proteins play an important role in genome replication and
packaging (Jayaram et al., 2004). NSP1, an RNA-binding protein, appears to be
nonessential for virus replication and is the least conserved of the viral proteins (Estes,
2001); however, it may play a role in modulating the innate immune response and
6promoting viral cell-to-cell spread (Barro and Patton, 2005). NSP2 and NSP5 are
involved in the formation of the viroplasms, electron dense inclusion bodies in which
much of the RV replication occurs (Fabbretti et al., 1999; Gallegos and Patton, 1989)
and in the synthesis and packaging of the viral RNA (Jayaram et al., 2004; Lopez et al.,
2005a). NSP6 interacts with NSP5 and accumulates in the viroplasms. NSP6 is encoded
on RV gene 11 with NSP5; however, the function of NSP6 remains unknown and does
not appear to be essential for virus replication, at least in cultured cells (Lopez et al.,
2005a). NSP3, a functional homolog of cellular poly (A) binding protein (PABP),
facilitates the translation of the viral transcripts by binding eIF4G and viral mRNAs,
enabling circularizing and delivery to the ribosomes, which represses host protein
synthesis (Jayaram et al., 2004; Padilla-Noriega et al., 2002; Varani and Allain, 2002).
NSP4 acts as a viral enterotoxin involved in the intracellular signaling pathway (J. M.
Ball, personal communication, August 31, 2004) and will be discussed in detail later.
Rotavirus Replication and Morphogenesis
RV infection is initiated with the attachment and entry of the virus via a multi-
step process that involves sequential interactions with cell surface molecules (Lopez and
Arias, 2004; Mendez et al., 1999). Attachment to the cell is mediated by proteolytic
cleavage of VP4 into VP5 and VP8 (Jayaram et al., 2004) which significantly enhances
viral infectivity (Arias et al., 1996) and aides in cell entry (Kaljot et al., 1988). VP8 is
involved in initial binding to the cell, while VP5 functions in membrane
permeabilization, viral entry, and uncoating (Golantsova et al., 2004; Pesavento et al.,
2006). The neuraminidase-sensitive (NA) strains interact with sialic acid (SA) through
7VP8 with broad specificity followed by more specific viral surface protein interaction
with other cell receptors such as integrins or heat shock cognate protein hsc70
(Dormitzer et al., 2002; Lopez and Arias, 2004; Zarate et al., 2000). The NA-insensitive
strains, such as the nar3 mutant strain of Rhesus RV, interacts directly with integrin
21 through VP5 (Gonzalez et al., 2000; Lopez and Arias, 2006; Zarate et al., 2000).
These integrin subunits,2 and3, and hsp70 have been shown to occur in lipid rafts of
MA104 cells (Isa et al., 2004). Additionally, when cholesterol is sequestered from the
cell membrane, RV infectivity is reduced by 90% and inhibiting glycoprotein synthesis
partially blocks infectivity of both NA-sensitive and NA-insensitive RV strains
(Guerrero et al., 2000). These data suggest an important role for lipid rafts in RV cell
entry.
Once inside the cell, the low [Ca++]I promotes uncoating and the activation of
VP1, the viral polymerase. The uncoating event involves the loss of the outer capsid
VP7 and the VP4 spikes resulting in the Double Layer Particle (DLP) in which
transcription occurs. The transcription process requires VPI, VP2, VP3, VP6, NSP1,
NSP2, and NSP3. Transcription of the viral genomic minus strands to yield the eleven
full length 5’capped plus stranded mRNA takes place in the transcriptionally competent
DLP. The nascent (+) mRNAs are extruded through type 1 channels into the cytosol.
Although RV mRNAs do not contain Poly (A) tails, the N-terminal region of NSP3
interacts with a 3’ consensus sequence in the 11 RV mRNA (Jayaram et al., 2004). The
C-terminal region of NSP3 has a strong affinity for the eukaryotic initiation factor (eIF)
so that the accumulation of NSP3 in the cytosol results in a decrease in the translation of
8cellular proteins by triggering the removal of the cellular poly (A)-binding protein
(PABP) from the eukaryotic initiation factor. Viral protein synthesis is instigated by the
delivery of the mRNAs to the host translation machinery because the C-terminal region
of NSP3 has a strong affinity for the eIF (Jayaram et al., 2004; Padilla-Noriega et al.,
2002; Varani and Allain, 2002).
Replication and assembly of the progeny RV occur in electron dense inclusion
bodies know as viroplasms. NSP2 and NSP5 form the viroplasm and are required for
replication and assembly (Fabbretti et al. 1999; Silvestri et al., 2004). The viroplasm not
only forms the DLP from VP1, VP2, VP3, and VP6 that has been concentrated within
this inclusion body, but also serves as the site of production of the nascent genomic ds
RNA. The DLP is formed when copies of the 11 ds RNAs are packaged with VP1 and
VP3 within VP2 (SLP) followed by packaging in VP6. The TLP is formed by an NSP4-
mediated process in which the DLP is pulled form the viroplasm into the endoplasmic
reticulum (ER), acquiring the outer capsid proteins (VP7 and possibly VP4) and a
transient envelope (Lopez et al. 2005b). The VP7 coalesces with the DLPs by an
unknown mechanism forming the TLPs. The transient envelope is lost upon exit from
the ER and the TLPs are delivered to the apical surface of intestinal cells (Jourdan et al.,
1997). In infected cells, VP4 has been shown to traffic to the PM where it probably
assembles onto the viral particle via the NSP4-VP4 binding site at amino acids 112-147
of NSP4 (Figure 1.2) (Bergmann et al., 1989; Pesavento et al., 2006; Taylor et al., 1996).
Lipid rafts have been implicated as a possible method of delivery of progeny virus,
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because infectious particles have been isolated in the raft fractions from in vitro and in
vivo samples (Cuadras and Greenberg, 2003).
Figure 1.2. Linear schematic of structural and functional domains of NSP4. The 175 aa residues of
NSP4 have 3 N-terminal hydrophobic domains H1, H2, and H3 and a single transmembrane domain (TM).
AAH, CCD indicates the amphipathic alpha helical region that folds as a coiled coil domain. The C-
terminal residues contain the VP6 binding site, the tubulin-binding domain, the VP4 binding site, and a
variable domain. The caveolin-1 binding site and enterotoxic peptide coincide (aa 114-135). site at amino
acids 112-147 of NSP4 PM (Bergmann et al., 1989; Pesavento et al., 2006; Taylor et al., 1996).
NSP4
As noted above, NSP4 functions as an intracellular receptor essential to RV
morphogenesis in which DLPs are pulled from the viroplasms across the ER membrane
by NSP4 (Lopez et al., 2005b) through binding to VP6 at amino acid residues 161-175
of NSP4 (Bergmann et al., 1989; Taylor et al., 1996). The NSP4 affinity for VP6 may be
the driving force for DLP translocation into the ER through VP7-containing membrane
patches and the addition VP7 to the DLP and possibly VP4, although this is
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controversial (Au et al., 1989; Pesavento et al., 2006; Taylor et al., 1996). VP4 may
assemble onto the viral particle via the NSP4-VP4 binding site at amino acids 112-147
of NSP4 at the PM (Bergmann et al., 1989; Pesavento et al., 2006; Taylor et al., 1996).
The infectious viral particle lacking NSP4 is released from the cell.
Also, NSP4 functions in RV pathogenesis as indicated by the induction of a
specific, age and dose-dependant diarrhea in neonatal mice as a result of the exogenous
addition of either NSP4 or the enterotoxic peptide 114-135 (Ball et al., 1996). This initial
diarrheal response occurs in the absence of histologic lesions and is a result of an
intracellular calcium [Ca+2]i –mediated mechanism that results in chloride (Cl-) secretion
and accumulation of fluids in the mouse pup intestinal loops (Ball et al., 1996; Dong et
al., 1997). NSP4 mediates [Ca+2]i mobilization by both exogenous addition and
endogenous expression by two distinct mechanisms. Exogenously added NSP4
mobilizes [Ca2+]i levels through a receptor-mediated, phospholipase C (PLC)-dependent
pathway (Brunet et al., 2000; Dong et al., 1997; Tian et al., 1994, 1995, 1996), whereas
endogenously expressed NSP4 mobilizes [Ca2+]i by a phospholipase C (PLC)-
independent mechanism (Dong et al., 1997; Tian et al., 1995). The interplay of NSP4
with Ca+2 promotes a high [Ca2+]i required for RV outer capsid structural stability as well
as RV maturation (Michelangeli et al., 1995; Ruiz et al., 2000).
NSP4 may contribute to disease by eliciting diarrhea or by disrupting other
cellular functions. The viral enterotoxin has been implicated in inducing loss of
transepithelial resistance in polarized MDCK cells (Tafazoli et al., 2001) resulting in
disruption of tight junctions in the epithelial barrier cells promoting fluid secretion and
11
diarrhea. Additionally, NSP4 has been shown to disrupt the Na+ -D-glucose symporter in
rabbit brush border membranes causing changes in the intracellular ion concentrations
and impairing water re-absorption (Halaihel et al., 2000).
NSP4, the only non-structural protein that does not appear to react with the RNA,
acts as a viral enterotoxin involved in the intracellular signaling pathway (J. M. Ball,
personal communication, August 31, 2004), functions as a modulator of viral
transcription (Silvestri et al. 2005), and plays a role in viral assembly and
morphogenesis. When gene 10, which encodes NSP4, is silenced in RV infected cells
viral transcription is increased but viroplasm formation is significantly decreased (Lopez
et al., 2005b; Silvestri, et al., 2005). The NSP4 viral enterotoxin is implicated in causing
the initial diarrhea symptoms prior to detection of histological lesions in the intestine
(Ball et al., 1996). NSP4 is synthesized as a primary translation product (Figure 1.1B)
containing 175 amino acids (aa) with a molecular weight of 20kDa (J. M. Ball, personal
communication, August 31, 2004). This primary translation product is modified by co-
translational glycosylation to 29K and oligosaccharide processing to the mature 28kDa
glycoprotein (Ericson et al., 1983a), which inserts into the endoplasmic reticulum (ER)
bilayer and is anchored by a hydrophobic transmembrane domain (aa 24-44) (Bergmann
et al., 1989) such that N-terminal 21 aa reside in the ER lumen and the C-terminal
residues 45-175 function as a cytoplasmic tail (Bergmann et al., 1989; Chan et al., 1988).
Figure 1.2 shows a linear schematic of structural and functional domains of
NSP4 (Ball et al., 2005). The 175 residues of NSP4 have 3 N-terminal hydrophobic
domains H1 (aa 7-21), H2 (aa 28-47), and H3 (aa 67-85) (Chan et al., 1988).
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Glycosylation sites (CHO) occur at aa 8 and 18. A single transmembrane domain (TM)
localizes to aa 22-44, but varies with the RV strain. Crystallographic analyses of NSP495-
137 indicate that it exists as a tetrameric coiled-coil domain (CCD) containing an
amphipathic alpha helical (AAH) with distinct polar and hydrophobic faces, and
functions in oligomerization (Parr et al. 2006; Bowman et al., 2000; Taylor et al., 1996).
This unique AAH has both positively and negatively charged regions within the polar
face. The C-terminal residues contain the VP6 binding site at aa 161-175, the tubulin-
binding domain (aa 156-175), and the VP4 binding site (aa 112-148). The enterotoxic
peptide coincides with the caveolin-1 binding site.
NSP4 is traditionally described as an ER transmembrane glycoprotein because of
its role in viral particle morphogenesis at the ER and because of sensitivity of the NSP4
glycosylation sites (CHO) to Endo--N acetylglucosaminidase H (endo H) (Bergmann et
al., 1989; Ericson et al., 1983a, 1983b). NSP4’s high mannose glycosylation indicates a
lack of Golgi-specific processing, which supports studies showing NSP4 traffics from
the ER by a pathway that bypasses the Golgi (Bergmann et al., 1989; Berkova et al.,
2003; Cuadras and Greenberg, 2003).
The C-terminal NSP4 fragment (aa 112-175) has been isolated from culture
medium of baculovirus-gene 10 recombinant infected Spodoptera frugiperda (SF9)
insect cells and RV-infected mammalian cells (Zhang et al., 2000). NSP4114-135 has been
shown to interact with the extracellular proteins laminin-3 and fibronectin in yeast-two
hybrid assays, which was confirmed by coimmunoprecipitation (Boshuizen et al., 2004).
Additionally, Boshuizen et al. found that NSP4 was present in infected enterocytes and
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in the basement membrane (BM) of infected neonatal mice and colocalized with
laminin-beta3, indicating a physiological interaction at the BM. Similarly, NSP4
colocalizes with Na+/K+ ATPase, a PM marker protein, the NSP4 C-terminus is exposed
on the exofacial surface of RV-infected mammalian cells, and full-length, high-mannose
glycosylated NSP4 is present in the caveolae membrane fraction of RV-infected
mammalian cells (Storey et al., 2007).
The NSP4 protein has been shown to localize in other areas of the cell. NSP4
binds microtubules and has been located in the ER-Golgi intermediate compartments
(ERGIC) (Xu et al., 2000). In infected cells, vesicular NSP4 tagged with Enhanced
Green Fluorescent Protein (NSP4-EGFP) colocalized with the autophagosomal marker
LC3 in cap-like structures associated with viroplasms, the site of nascent viral RNA
replication (Berkova et al., 2006).
It has been suggested that NSP4 may associate with cellular lipid rafts during
infection. Lipid rafts purified from infected cells have been shown to contain infectious
RV particles, structural proteins, specifically VP4, and nonstructural proteins including
NSP4 (Sapin et al., 2002). Additionally, Cuadras et al. (2006) have shown that silencing
VP4 and NSP4 reduced the occurrence of RV particles with lipid rafts. Using circular
dichroism and filter binding assays, Huang et al. (2001) report that NSP4 and NSP4114-
135 preferentially interact with highly-curved lipid vesicles that resemble caveolae, a
cholesterol- and sphingomyelin-rich PM microdomain (Huang et al., 2001, 2004).
Recent research shows that NSP4 has been isolated with PM caveolae of infected cells
from which ER resident proteins have been removed (Storey et al., 2007). NSP4 has
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been shown to colocalize with caveolin-1 in reticular structures surrounding the nucleus,
in the cytosol, and at the cell periphery in both RV-infected and transfected mammalian
cells (Parr et al., 2006). Coimmunoprecipitation of the NSP4-caveolin-1 complexes from
RV-infected mammalian cells confirmed this interaction occurs during infection
(Gibbons, 2007). Additionally, Parr et al. have demonstrated a direct interaction between
NSP4 residues 112-140 of full-length NSP4 and caveolin-1 using the Pro-Quest yeast-
two hybrid system and further delineated the binding domain to amino acids 114-135 in
peptide binding assays using caveolin-1 from mammalian cell lysates and Sepharose-
bound NSP4-specific peptides.
Caveolae and Caveolin-1
Caveolae are invaginations of the plasma membrane containing caveolin proteins
(caveolin-1, -2, and -3) and are considered a subset of lipid rafts. These invaginations
originally named “plasmalemmal vesicles” (Palade, 1953) are small (50-100 nanometer)
and occur in most cell types (Thomas and Smart, 2008) including endothelial cells. Early
researchers proposed that “plasmalemmal vesicles” or “caveolae intracellulare” were
capable of communicating with the exterior of the cell as well as shuttle molecules
within the cell (Simionescu et al., 1983). While the structure is typically flask-shaped,
other morphologies such as flat, tubular, and vesicular are noted. Caveolae are
considered to be a highly curved subset of lipid rafts that contain the integral membrane
protein caveolin-1 and are rich in cholesterol, sphingomyelin, glycosphingolipids, and
signaling molecules (Couet et al., 2001). Caveolae differ from other lipid rafts in that
they have a striated coat and contain caveolin proteins (Liu et al., 2002; Rothberg et al.,
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1992). Caveolae rafts are not functionally the same as non-caveolin containing lipid
rafts. Caveolin influences cellular process by forming homo- and hetero-oligomers (Das
et al., 1999; Scheiffele et al., 1998; Schlegel and Lisanti, 2000), interact with signaling
molecules (Robbins et al., 1995; Shenoy-Scaria et al., 1994), and by regulating
cholesterol content in caveolae (Uittenbogaard and Smart, 2000). Caveolae functions
include (a) transport, including endocytosis, transcytosis, and cholesterol transport; (b)
functioning in Ca2+ homeostasis; and (c) signal transduction by regulating a wide variety
of signaling pathways.
The family of caveolin proteins includes caveolin-1, -2, and -3, which are
referred to as caveolae coat proteins. These proteins serve as identifying markers for
caveolae with molecular mass between 18 and 22kD. While the three caveolins are
compositionally different, they all contain the caveolin signature sequence of eight aa
residues (FEDVIAEP) (Tang et al., 1996).
Caveolin-1 is a protein of 178 aa and occurs as two isoforms, caveolin-1or full
length and caveolin-1with the beta form being residues 32-178 of the alpha form. Both
forms induce caveolae formation in vitro (Fujimoto et al., 2000). Caveolin-1 is the main
structural protein of caveolae, serving as the caveolae backbone. It regulates the
transport of cholesterol to and from caveolae (Kurzchalia et al., 1992; Smart et al., 1994,
1996; Uittenbogaard et al., 1998) and regulates a variety of signal transduction activities
of caveolae resident proteins (Chun et al., 1994; Fujimoto, 1993; Li et al., 1996; Song et
al., 1996). Stable oligomers of caveolin-1 form filaments along the cytoplasmic face that
serve to regulate the formation of caveolae vesicles, known as caveosomes and serve as
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a scaffold for these vesicles (Li et al., 1998). Cavesomes, which were first characterized
as intermediates in the trafficking of SV40 virus from the cell surface to the ER
(Pelkmans et al., 2001), are non-acidic caveolin-1 vesicles lacking both endosomal and
lysosomal markers (Nichols, 2002). The oligomers are stabilized by the palmitoylation
of three cysteine residues that function in caveolin-cholesterol binding and transport to
the PM (Dietzen et al., 1995; Uittenbogaard and Smart, 2000). Both termini of caveolin-
1 are exposed in the cytoplasm (Figure 1.3), which results from formation of a hairpin
loop in the cytoplasmic leaflet of the PM by a central intermembrane domain (aa 97-
131) (Anderson, 1998). The caveolin scaffolding domain (CSD), aa 82-101, functions in
membrane attachment resulting in aa residues 82-101 being identified as the N-terminal
membrane attachment domain (N-MAD). Similarly, aa residues 135-150 are identified
as the C-terminal membrane attachment domain.
Caveolin-2 forms three isoforms, however, the functional significance of the
isoforms is not clear (Anderson, 1998). Caveolin-2 is found in the same types of cells as
and colocalizes with caveolin-1 and requires it to form caveolae. The caveolin hetero-
oligmers found in most cells are made of caveolin-1 and -2 (Thomas and Smart, 2008).
Caveolin-3, a muscle specific caveolin, is functionally and structurally similar to
caveolin-1, but is 27 aa shorter and can form caveolae independent of caveolin-1 (Tang
et al., 1996).
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Figure 1.3. Membrane topology and domains of caveolin-1. Caveolin attaches to the plasma membrane
(PM) through the centrally located transmembrane domain (TMD) at aa 102-134 forming a putative
hairpin within the PM, resulting in both termini of caveolin-1 being exposed in the cytoplasm. Additional
attachment to the PM occurs through the caveolin scaffolding domain (CSD, aa102-101), which is known
as the N-terminal membrane attachment domain (N-MAD) and the C-terminal membrane attachment
domain (C-MAD, aa135-150). Caveolin-1 monomers form stable oligomers through attachment at the
oligomerization domain (OD, aa 61-101). Palmitoylation of three cysteine residues (133, 143, and 156)
function to stabilize caveolin-1 oligomers.
Cholesterol is a major component of caveolae and stabilizes the caveolae
structure at the PM (Simionescu, 1983). Cholesterol levels are in constant flux in and out
of caveolae suggesting that caveolae function in cholesterol transport (Smart et al., 1994;
Storey et al., 2007). Movement of cholesterol in and out of high density lipoproteins
(HDL) is controlled by caveolin-1 (Graf et al., 1999). Additionally, cholesterol has
transcriptional control of caveolin-1 through sterol regulatory elements in the caveolin-1
promoter, such that high concentration of intracellular cholesterol stimulate its
transcription and low levels decrease it (Bist et al., 1997; Fielding et al., 1997).
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NSP4 and Caveolin-1
The multifunctional roles of caveolin-1, including structural protein of caveolae,
signal transduction, vesicular, transport, and residence in the PM make it a likely cellular
molecule for RV to use to facilitate infection, morphogenesis, and pathogenesis.
Caveolin-1 is upregulated in RV-infected Caco-2 cells (Cuadras et al., 2002) suggesting
a modulation of its transcription by RV. Full-length, endo-H sensitive NSP4 is present in
cavitation-sucrose chromatography caveolae from RV SA11-4F-infected MDCK cells
(Storey et al., 2007). NSP4 and caveolin-1 have been shown to colocalize at perinuclear
sites, in cytoplasmic structures, and at the cell periphery in RV-infected MDCK cells at
both early and late time points (Storey et al., 2007). In NSP4-transfected cells, that is in
the absence of all other viral proteins, NSP4 had a similar distribution pattern as the RV-
infected cells, i.e., at the cell periphery, in the cytosol, and it colocalized with caveolin-1
at intracellular sites similar to the RV-infected cells (Storey et al., 2007). The
colocalization of NSP4 and caveolin-1 during RV infection or NSP4 transfection
resolved the proteins to within about 200 nm, while FRET analyses with Cy2- and Cy3-
labeled probes resolved the NSP4-caveolin-1 interaction to an area of less than 10 nm in
radius. The positive FRET reaction placed at least some portion of the NSP4 and
caveolin-1 protein pools within 10 nm of each other, highly indicative of a protein-
protein interaction (Storey et al., 2007).
The purpose of this research was to identify the region or regions of the NSP4 C-
terminal amphipathic alpha helix (AAH) that are sufficient for binding caveolin-1.
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Hypothesis
We hypothesized that hydrophobic face of the NSP4 AAH binds caveolin-1 via a
hydrophobic interaction and that a minimum of three hydrophobic residues in the
hydrophobic face of the NSP4 AAH are required for binding caveolin-1.
Specific Aims
 Aim 1: Determine if the polar or hydrophobic face of the NSP4 AAH bind
caveolin-1 using mutants that disrupt the polar or the hydrophobic face.
 Aim 2: Design and clone NSP4 hydrophobic mutants with contiguous
hydrophobic residues in the C-terminal hydrophobic face of the NSP4 AAH.
Determine which hydrophobic residues in the C-terminal hydrophobic face of
the NSP4 AAH are sufficient for binding caveolin-1 using mutant NSP4
proteins in yeast-two hybrid assays.
 Aim 3: Verify direct interaction between caveolin-1 and yeast two-hybrid
positive mutant NSP4 proteins using peptide binding assays.
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CHAPTER II
THE HYDROPHOBIC FACE OF THE ROTAVIRUS NSP4 EXTENDED
AMPHIPATHIC ALPHA HELIX BINDS CAVEOLIN-1
Overview
A direct interaction between the Rotavirus NSP4 and caveolin-1, the structural
protein of caveolae, has been shown by yeast two-hybrid, peptide binding assays, co-
immunoprecipitation, and Fluorescence Resonance Energy Transfer (FRET) analyses.
Using seven deletion mutants of NSP4, binding to caveolin-1 has been delineated to the
enterotoxic domain within the C-terminal amphipathic alpha helix (AAH) of NSP4.
Alterations in the charged face or the hydrophobic face of the C-terminal AAH have
demonstrated a preferential binding of the hydrophobic face of NSP4 to caveolin-1. In
this study, we further explored this finding using mutagenesis, yeast 2-hybrid, and
peptide binding assay.
This study localized the NSP4 binding domain for caveolin-1 to one critical
hydrophobic aa (L116) and at least one other aa (L127or L134) in the same plane as
L116 plus at least one other aa (I113 or Y131) in the other plane of the hydrophobic
face. These data provide evidence that conformational and hydrophobic constraints play
an important role in the NSP4 to caveolin-1 association.
Introduction
Rotavirus (RV) causes severe diarrhea in young animals and children resulting in
the annual hospitalization of nearly 2 million children and the death of over 440,000
children less than five years of age worldwide (Fischer et al, 2007; Pasashar et al. 2003).
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RV induces both secretory and maladsorbtive diarrhea, both of which are multifactorial
(Estes et al., 2001; Morris and Estes, 2001). One mechanism of secretory diarrhea has
been elucidated with the identification of the RV nonstructural protein 4 (NSP4) as the
first viral enterotoxin (Ball et al., 1996). In this study NSP4 and the enterotoxic peptide,
amino acids (aa) 114-135, induced diarrhea in young mice by promoting Cl- secretory
currents via a calcium-mediated pathway in the absence of histological alterations (Ball
et al., 1996).
NSP4, initially identified as an endoplasmic reticulum (ER) resident
glycoprotein, is essential to RV morphogenesis (Au et al., 1989). To further define the
function(s) of NSP4 in RV morphogenesis, silencing RNA (siRNA) studies were
performed on RV-infected cells (Lopez et al., 2005b). These studies demonstrate that in
the absence of functional NSP4, there is: (a) an abnormal distribution of viral proteins in
the viroplasm, (b) little to no virus particles present, (c) an accumulation of empty virus
particles (Lopez et al., 2005a; Silvestri et al., 2005), and (d) an up-regulation of viral
transcription (Silvestri et al, 2005). Taken together, these data show the critical role of
NSP4 in viral morphogenesis suggesting that NSP4 performs an important regulatory
role in the maturation of the transcriptionally active double-layered particles to triple-
layered particles.
Increasing evidence has shown NSP4 functions as an enterotoxin by activating a
signal transduction pathway initiated at the plasma membrane (PM) (Brunet et al., 2000;
Tian et al., 1994, 1995). Exogenously added NSP4 mobilizes [Ca2+]i levels through a
receptor-mediated, phospholipase C (PLC)-dependent pathway (Brunet et al., 2000;
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Dong et al., 1997; Tian et al., 1994, 1995, 1996), whereas endogenously expressed NSP4
mobilizes [Ca2+]i by a phospholipase C (PLC)-independent mechanism (Dong et al.,
1997; Tian et al., 1995).
Identification of a C-terminal fragment of NSP4 (residues 112-175) in RV-
infected culture media provide the first experimental evidence that at least a portion of
NSP4 leaves the ER (Zhang et al. 2000). Subsequent studies confirm the presence of
NSP4 at multiple locations in RV-infected cells (Berkova et al., 2006; Boshuizen et al.,
2004; Cuadras and Greenberg, 2003; Parr et al., 2006; Xu et al., 2000). Co-localization
studies show NSP4 and caveolin-1 throughout the cell and at the cell periphery (Parr et
al, 2006). Interactions between NSP4 and the extracellular matrix proteins, laminin-
beta3 and fibronectin have been demonstrated at the basement membrane of rodent
intestines and in Yeast-2 Hybrid assays (Boshuizen et al., 2004). Co-localization of
NSP4-EGFP with a viroplasm marker, NSP5, and an autophagic vesicle marker, LC3,
using confocal imaging indicates NSP4 transport is via a calcium-dependent vesicular
pathway that bypasses the Golgi (Berkova et al., 2006). Together, these data clearly
support the exit of NSP4 from the ER and the co-localization with caveolin-1 at
perinuclear reticular structures, in the cytosol, and at the cell periphery in both RV-
infected and transfected mammalian cells. Furthermore, NSP4 associates with cellular
proteins that could be implicated in protein trafficking (Berkova et al., 2006; Huang et
al., 2004; Silvestri et al., 2005; Storey et al., 2007; Xu et al., 2000).
Data demonstrate preferential binding of NSP4 and NSP4114-135 to SUVs that are
caveolae-like model membranes, suggesting the caveolae membrane system may serve
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as a means of NSP4 transport (Huang et al., 2001, 2004). Caveolin-1 is found in the
intestine, interacts with cholesterol, and functions to transport de novo synthesized
cholesterol to and from the ER and PM caveolae (Devaux and Morris, 2004; Schroeder
et al., 2001; Smart et al., 1996; Uittenbogaard et al., 1998. Also, caveolin-1 acts as a
scaffolding protein in caveolae for signaling molecules, including those involved in
calcium homeostasis (Cheng et al., 2006; Field et al., 1998; Hailstones et al., 1998). In
summary, the multi-functional caveolin-1 is likely candidate to facilitate NSP4
movement within the cell as it is involved in cellular activities.
Subsequently, we identified a direct interaction between the structural protein of
caveolae, caveolin-1, and NSP4 (Parr et al., 2006). Further analyses have delineated the
NSP4 binding site for caveolin-1 to aa 114-135, the enterotoxic domain, using in vivo
yeast two-hybrid, in vitro binding, and co-immunoprecipitation assays (Parr et al., 2006).
The goal of the current study was to extend these findings and determine if the
secondary structure of the NSP495-137 amphipathic alpha helix interacts with caveolin-1
(Bowman et al., 2000; Taylor et al., 1996). To determine the aa residues in NSP4113-135
that bind caveolin-1, nine NSP4 site-directed mutants were constructed that disrupted
either the charged or hydrophobic face of the AAH in full-length NSP4 (FLNSP4) and
NSP446-175.
Materials and Methods
Antibodies and Peptides
Synthetic peptides to NSP4 (residues 2-22, 114-135, and 150-175) and caveolin-
1 (residues 2-31, 19-40, 76-101, and 161-178) were generated in our laboratory as
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previously described (Huang et al. 2001). NSP4 and caveolin-1 peptide specific
antibodies were generated in rabbits to NSP4 and caveolin-1 residues 2-31 as previously
described (Huang et al., 2004; Swaggerty et al., 2004). Rabbit Ig anti-caveolin-1 N1-97
(purified polyclonal Antibody generated from human caveolin -1) was purchased from
BD Biosciences (San Jose, CA). These antibodies were used as primary antibodies in
Western blot assays as previously described (Fischer et al., 2007; Mir et al., 2007; Parr
and Ball, 2003; Parr et al., 2006; Zhou et al., 2004). Reactive bands were visualized by
the addition of goat HRPO-anti-rabbit IgG and SuperSignal West Pico or Femto
chemiluminescent substrate (Pierce, Rockford, IL), and exposure and development of x-
ray film.
Mammalian Cell Lines and Yeast Strains
Madin-Darby Canine Kidney (MDCK) cells were obtained from ATCC
(Rockville, MD) and maintained in Dulbecco’s modified Eagle medium (DMEM;
Gibco, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS), glutamine
(2 mM), penicillin-streptomycin (100 ug/ml) and non-essential amino acid (1X) (Sigma,
St. Louis, MO). Saccharomyces cerevisiae strain MaV203 (MAT, leu2-3,112, trp1-901,
his3200, ade2-101, gal4, gal80, SPAL10::URA3, GAL1::lacZ, HIS3UASGAL1::
HIS3@LYS2, can1r, cyh2r) was used for all yeast two-hybrid analyses (Vidal et al.,
1996). A collection of yeast strains that contain plasmid pairs expressing fusion proteins
with a spectrum of interaction strengths [pPC97 (GAL4-DB, LEU2), pPC97-CYH2S and
pPC86 (GAL4-AD, TRP1)] were used as controls (Invitrogen Life Technologies, 2002;
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Vidal et al., 1996). The control plasmids pDBleu and pEXP-AD507 contain only the
Gal4 DNA-binding domain (BD) and the Gal4 activating-domain (AD) respectively.
The Saccharomyces cerevisiae yeast strain InVSc1 (MAThis3-1, leu2, trp1-
289, ura3-52; Invitrogen) was used to express full-length FLNSP4, FLNSP4Ala, and the
eight NSP446-175 mutant proteins in the inducible yeast expression system.
Construction of Plasmids
Two sets of NSP4 clones were prepared for separate assays. Full-length (FL)
NSP4, NSP4Ala and NSP4HydroMut (FLNSP4, FLNSP4Ala and FLNSP4HydroMut) were
constructed using overlapping site-directed mutagenesis and used for in vitro binding
assays (Figure 2.1A). Because we have observed stronger positive interaction between
NSP4 and caveolin-1 in yeast 2-hybrid assays using a NSP446-175, the N-terminal
deletion mutant lacking two N-terminal hydrophobic domains (Parr et al., 2006), we
utilized overlapping site-directed mutagenesis to construct the same alanine and charged
amino acids substitutions in the NSP446-175 clone (NSP4Ala and NSP4HydroMut). The
primer sets for these mutants and other mutants used in this research are shown in Figure
2.1A.
Figure 2.1. NSP4 mutants. A. Linear schematics of the NSP4 mutants used in this study are given on the left. The individual aa that were mutated are indicated
by asterisks and are given to the right of each drawing as the original aa + position + new aa, i.e. D114A means aa 114 aspartic acid was mutated to alanine. The
PCR fragments were produced using the forward and reverse primers listed to the right of each construct and cloned into the DNA-binding domain, pD22, the
activation-domain, pD32, and pY52Dest plasmids of the Invitrogen Gateway™ System. The linear schematics include of the full-length alanine mutant
(FLNSP4Ala) and the N-terminal deletion mutant (NSP4Ala) in which charged residues were mutated to alanine; the full-length hydromutant (FLNSP4Hydromut) and
the N-terminal deletion mutant (NSP4Hydromut) in which hydrophobic residues were mutated to charged residues, Rev 1; Rev 2; Rev 3; Rev2 M116, 124,127A;
Rev2M116A; Rev1, 2M127A; and Rev1M124, 127A.
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B.
Figure 2.1. NSP4 mutants continued . B. Alignment of the FLNSP4 and the N-terminal deletion mutants.
To disrupt the charged face, six charged amino acids were changed to alanine
(D114A, K115A, R119A, E125A, D132A, and K133A) in both FLNSP4Ala and NSP4Ala
(Figure 2.1A). To disrupt the hydrophobic face of NSP4, three amino acids localized to
the hydrophobic face of the C-terminal AAH were changed to charged residues (I113R,
V124K, and Y131D) FLNSP4HydroMut, and NSP4HydroMut (Figure 2.1A). The mutant PCR
products were directionally cloned into the Invitrogen Gateway™ Entry vector,
pENTR11 (Invitrogen, CA), sequence verified, and cloned into the Invitrogen
Gateway™ Destination vectors pDEST22 and pDEST32 as previously described (Parr et
al., 2006; Zhou et al., 2004).
Yeast Two-Hybrid Screening
MaV203 yeast were co-transformed with caveolin-1, -NSP4, -NSP4Ala or –
NSP4HydroMut in the appropriate pD22 and pD32 vectors by a modified lithium acetate
procedure as previously described (Gietz and Woods, 2002). Briefly, S. cerevisiae
MaV203 was grown in YPAD (yeast extract, bacto-peptone, 0.01mM adenine
hemifulfate, 2% dextrose), overnight at 30 C˚ with shaking, diluted to an OD600 of 0.5,
and incubated at 30 C˚ with shaking to an OD600 of 2. The cells were washed with dH2O,
pelleted, and washed with 2 ml of 100 mM lithium acetate (LiAc), pelleted and
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resuspended in 800L of 100mM LiAc, divided into 50L aliquots for individual
transformations. Aliquots were pelleted and the following solutions were added in order:
240L of 50% PEG (3350 mw); 36L of 1M LiAc; 25L of salmon sperm DNA
(2mg/ml); 50L of dH2O and 100ng of each plasmid DNA. The yeast were heat shocked
at 42 C˚ for 45 min and then incubated at 30 C˚ for 1h before plating onto complete
synthetic medium lacking leucine and tryptophan (CSM -Leu-Trp). Transformants were
grown at 30 C˚ for 72 hrs on CSM-Leu-Trp and replica plated onto selective media to
identify colonies containing both plasmids. The interaction of candidate protein pairs
was assessed by the induction of three independent reporter genes (URA3, His3, lacZ),
which were monitored on selective media and by-galactosidase assays. Ninety clones
of each NSP4 mutant construct (bait or prey) were screened for interaction with
caveolin-1. Full length NSP4 was used as a positive control in addition to the panel of
controls provided by the manufacturer.
URA3 was monitored by cell growth patterns on CSM -Leu-Trp-Ura and CSM-
Leu-Trp + 0.2% 5-fluoroorotic acid (FOA). The yeast two-hybrid-dependent induction of
URA3 results in the conversion of 5-fluoroorotic acid (5FOA) to 5-fluorouracil, which is
toxic and inhibits the growth of yeast. Cells with interacting proteins grow on medium
lacking uracil, but are growth inhibited on medium containing 5FOA.
When HIS3 was transcribed, the growth of the co-transformed yeast was
inhibited in a dose-dependent manner by adding 3-amino-1, 2, 4-triazole (3AT: 25 mM,
50 mM, and 100 mM) to CSM- Leu-Trp-His (52). MaV203 expresses a basal level of
HIS3 that is inhibited with increasing concentrations of 3AT.
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Activation of the lacZ promoter was detected with an assay for-galactosidase
(-gal) expression. It was qualitatively assayed by plating the transformed yeast on
YPAD medium with a nitrocellulose filter. The presence-gal was detected by using the
substrate X-gal (5-bromo-4-chloro-3-indolyl--D-galactopyranoside). The induction of
the lacZ gene resulted in a blue color when assayed with X-gal. To quantitatively
measure-galactosidase activity, chlorophenol red--D-galactopyranoside (CPRG) was
used as the substrate. Three independent isolated colonies from each positive X-gal
sample and from X-gal negative samples were assayed in triplicate. Briefly, the X-gal
positive yeasts were streaked onto CSM-Leu-Trp medium, grown overnight at 30C.
Individual colonies were inoculated into 2.5ml CSM-Leu-Trp, incubated overnight at
30C with shaking. YPAD (5 mls) was inoculated with 1ml of the overnight culture,
which gave an approximate OD600 of 0.5, then incubated 30C with shaking until the
OD600 = 1.0-1.5. A 1.5ml aliquot of the culture was place in a microfuge tube,
centrifuged, pelleted, washed with the buffer solution sans the CPRG substrate, pelleted
again, followed by addition of the buffer solution containing the CPRG substrate and
incubated at 37C and monitored for development of a rusty yellow to red-brown color.
After color development, which varied from as little as 15 minutes to over 48 hours, the
reaction was stopped with 6mM zinc chloride (ZnCl2), the samples centrifuged, 200l
of the supernatant transferred a well of a 96-well plate, and the optical density was
determined with an ELISA reader. One-gal unit is defined as the amount of enzyme
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that hydrolyzes 1 mmol of CPRG chloramphenicol red and D-galactose per minute (Parr
et al., 2006; Zhou et al., 2004).
Western Blot Assays
The co-transformed yeast were grown in liquid CSM-Leu-Trp, and yeast protein
extracts were prepared using the Zymo Yeast Protein Extraction kit (Zymo Research,
CA). The yeast cell pellets were resuspended in PBS (pH 7.2) containing protease
inhibitors [100µM AEBSF, 80µM aprotinin, 5µM bestatin, 1.5µM E-64, 2µM leupeptin,
1µM pepstatin A, 100µM PMSF (Calbiochem-Novabiochem Corp., San Diego, CA)].
Micro bicinchoninic acid (BCA) protein assay (Pierce Biotechnology, Rockford, IL) was
used to quantify protein concentrations with bovine serum albumin according to the
manufacturer’s protocol. All lysates were separated by 12% SDS-PAGE, electroblotted
onto nitrocellulose membranes, probed with NSP4 or caveolin-1 peptide-specific
antibodies, and reactive bands were visualized by the addition of HRP-conjugated IgG
and SuperSignal® West Pico or Femto (for peptide binding assays only)
chemiluminescent substrate (Pierce) followed by exposure to Kodak X-OMAT film as
previously described (Parr and Ball, 2003; Parr et al., 2006; Zhou et al., 2004).
Expression of FLNSP4,Ful-Lengh Mutants and MSP4 Deletion Mutants
The entry level vectors encoding FLNSP4, FLNSP4Ala, FLNSP4HydroMut,
NSP4Rev1, NSP4Rev2, NSP4Rev3, NSP4Rev2M116, 124, 127A, NSP4 Rev1M124, 127A, NSP4 Rev1, 2
M127A, NSP4Rev2 116A were used to shuttle the NSP4 sequences into the inducible yeast
expression plasmid, pYES-DEST52 (Invitrogen) as described above. Transformants
were grown on CSM-Ura and colonies were induced with YPAG medium [yeast extract,
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peptone (Difco), 0.01 mM adenine sulfate, 2%galactose (Sigma)] to express the
encoded NSP4 proteins. Cells were grown in YPAG at 30°C for 24h, washed and
resuspended to an OD600 of 0.5 in YPAG and incubated at 30°C for 24h. Yeast lysates
were prepared using the Zymo Yeast Protein Extraction kit (Zymo Research, Orange,
CA) as previously described and were utilized in the peptide binding assays (Parr et al.,
2006; Zhou et al., 2004). Approximately 1 x 106 cells were pelleted and 25l Y-Lysis
buffer and 1l zymolase were added to the samples and incubated at 37°C for 1 h. The
cells were centrifuged at 400 x g for 5 min, resuspended in PBS (pH 7.2), containing
protease inhibitors [100µM AEBSF, 80µM aprotinin, 5µM bestatin, 1.5µM E-64, 2µM
leupeptin, 1µM pepstatin A, 100µM PMSF (Calbiochem-Novabiochem Corp., San
Diego, CA)]. Micro bicinchoninic acid (BCA) protein assay (Pierce Biotechnology,
Rockford, IL) was used to quantify protein concentrations with bovine serum albumin
according to the manufacturer’s protocol. The cell lysates were used in the in vitro
peptide binding and Western blot assays as described below.
In Vitro Peptide Binding Assay
To confirm the protein-protein interaction of caveolin-1 with FLNSP4, FLNSP4
mutants or NSP4 deletion mutants, synthetic peptides corresponding to either N-
caveolin-1 (residues 2-31 or 19-40), caveolin-1 containing only the scaffolding domain
residues 76-101, or C-caveolin-1 (residues 161-178) were attached to CNBr-activated
sepharose 4B beads as recommended by the manufacturer (Amersham Biosciences
Corp., Piscataway, NJ). Controls included Sepharose beads alone and lysates from
InVSc1without an expression plasmid insert. Cells lysates with approximately 2mg total
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protein was incubated with 50ml of a 50% slurry CNBr-activated sepharose 4B beads
with and without peptides overnight at 4ºC with gentle mixing. The beads were washed
three times with wash buffer (10 mM Tris pH 7.5; 10 mM Tris pH 7.5 + 0.5 M NaCl)
and resuspended in SDS-PAGE loading buffer. The proteins were separated on 12%
SDS-PAGE, transferred to nitrocellulose membranes and probed with caveolin-1- or
NSP4-specific antibodies in a Western blot assay.
EndoH Digestion of NSP4HydroMut Expressed in Yeast
To ensure that the lack of reactivity of FLNSP4HydroMut was not due to the lack of
glycosylation pattern that we previously have shown with NSP4 from RV-infected
MDCK cells (Parr et al., 2006), yeast expressing FLNSP4HydroMut were treated with
endoglycosidase H (Endo H). RV-infected MDCK cells were used as a control that
demonstrated normal NSP4 glycosylation pattern. Briefly, glycoprotein denaturing was
completed per manufacturer’s directions using the Endo H kit (New England Biolabs,
Ipswich, MA). Samples were mock treated or digested with Endo H for 1 h at 37°C. The
treated lysates were resolved by 12% SDS-PAGE, electrotransferred onto nitrocellulose
and probed with NSP4-specific antibody in a Western blot. A shift in the NSP4
molecular weight due to glycosidase treatment was visualized by chemiluminescence
(Parr et al., 2006).
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Results
NSP4- and Caveolin-1-fusion Proteins Are Present in the Co-transformed Yeast
To verify the presence of the encoded NSP4 clones and caveolin-1 GAL-4 fusion
proteins, the co-transformed lysates were probed with peptide specific antibodies, either
anti-NSP4150-175 or anti-caveolin-1 (Figure 2.2 A-D). Untransformed InVSc1
demonstrated a non-specific band at ~30 kD when blotted with both antisera (Figure
2.2A and B, lane 1). The fusion proteins pD22caveolin-1 (~34.9kD) were present in all
co-transformed yeast and pD32NSP446-175, Ala, HydroMut, Rev1, Rev2, and Rev3 (Figure 2.2 Panel
A). Similar results were obtained with the fusion proteins formed by the co-
transformation of pD22caveolin-1 with pD32NSP4 Rev1,2 M127A, pD32NSP4 Rev1,2 M124,
127A, pD32NSP4Rev2 M 116A, 124A, 127A, pD32NSP4Rev2 M116A (Figure 2.2 Panel C). The
NSP4 fusion proteins evaluated with caveolin-1-specific antibodies (panels B and D)
were expressed and were present at ~34.4kD (Figure 2.2B and D). These data confirm
that the encoded sequences from both plasmids are translated as fusion proteins.
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Figure 2.2. NSP4- and caveolin-fusion protein expression. To verify the presence of NSP4- and
caveolin-1 fusion proteins in the yeast-two-hybrid assay, Western blot analyses of the yeast co-
transformed with pD22cav-1 and each of the following: pD32NSP446-175, pD32NSP446-175Ala ,
pD32NSP446-175HydroMut, pD32NSP4Rev1, pD32NSP4 Rev2, pD32NSP4Rev3, pD32NSP4Rev2 M116A,
pD32NSP4Rev2 M 116A, 124A, 127A, pD32NSP4 Rev1,2 M127A, and pD32NSP4 Rev1,2 M124, 127A, were examined using
(A and C) rabbit anti-NSP4150-175 or (B and D) rabbit anti-Cav2-22. A. The non-transformed yeast
(InVSc1) only showed a non-specific band at ~29kD that was observed in all lanes. Lysates expressing
FLNSP4 demonstrated NSP4-specific bands at ~ 28, 24, and 20kD, and FLNSP4Hydromut showed bands
at ~ 28, 24kD. All of the co-transformed yeast demonstrated a NSP4-fusion protein band at ~ 34.4kD (A
and C). B. The same lysates showed faint contaminating bands above and below the 34.9kDspecific
caveolin-1- fusion protein bands. (B and D).
The Hydrophobic Face of the AAH of NSP4 Binds Caveolin-1
We previously have shown a protein-protein interaction between NSP4 residues
114-135 and caveolin-1 by yeast two-hybrid, in peptide binding, and
coimmunoprecipitation assays (Parr et al., 2006). In this study, we observed a stronger
interaction with NSP446-175 than with full-length protein; therefore, we performed the
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two hybrid assays with the N-terminal deleted NSP4. NSP4 residues 95-137 form an
amphipathic alpha helix (Bowman et al., 2000; Taylor et al., 1996), in which the putative
NSP4-caveolin-1 binding site occurs. To identify the precise aa in NSP4114-135 (Figure
2.3A) involved in binding caveolin-1, the AAH was disrupted by mutating the
hydrophobic face (NSP4HydroMut ) or charged face (NSP4Ala) as depicted in the helical
wheel diagram (Figure 2.3B and C). These mutants were then introduced into the
ProQuest™ Yeast Two-Hybrid System (Invitrogen). The pD22NSP446-175Ala and
pD22NSP446-175HydroMut, plasmids were co-transformed along with pD32caveolin-1
(CSM-Leu-Trp) (Table 2.1). Three independent co-transformations demonstrated
transformation efficiencies of ~ 2-5 x 106 transformants/g plasmid DNA (data not
shown), within the range of the standard efficiencies (greater than 1 x 106
transformants/g plasmid DNA) (Geitz and Woods, 2002). Similar results were obtained
when the experiments were repeated in reverse using pD32NSP446-175Ala and
pD32NSP446-175HydroMut along with pD22caveolin-1 (data not shown).
The growth patterns of the co-transformed yeast were monitored to detect the
activation of transcription from three chromosomally integrated reporter genes Ura3,
His3, and lacZ. Four growth phenotypes, His+(3ATR), Ura+, 5FOAS and -gal+, were
used to assess transcription activation of histidine, uracil and-galactosidase,
respectively. Control yeast, supplied with the ProQuest™™ Two-Hybrid System, and
only yeast co-transformed with pDest32 and pDest22 plasmids grew on CSM-Leu-Trp
medium.
Table 2.1. Analysis of Y2H assay of pD32-NSP4 mutants plus pD22-caveolin-1a
CSM Leu-Trp-
CSM Leu-Trp-His- + 3AT
12.5mM 50mM 100mM
CSM Leu-
Trp-Ura-
CSM Leu-Trp-
+ 0.2% 5FOA
-gal
Unitsb
Phenotypesc
2+ Control + - - + - 37 Positive
1+ Control + +/- - +/- +/- 0.334 Positive
Negative Control + +/- - - + 0.134 Negative
NSP4 46-175 + - - - +/- 1.39 Positive
NSP4 46-175Ala +/- - - - +/- 1.822 Positive
NSP4 46-175HydroMut + - - +/- + 0.105 Negative
NSP4 46-175Rev1 + - - - +/- 3.941 Positive
NSP4 46-175Rev2 + +/- - - +/- 3.042 Positive
NSP4 46-175Rev3 + +/- - +/- - 3.195 Positive
NSP4 46-175Rev2M116, 124, 127A + +/- - +/- +/- 0.056 Negative
NSP4 46-175Rev2M116A + - - - +/- 0.165 Negative
NSP4 46-175Rev1, 2M127A + +/- - - +/- 2.581 Positive
NSP4 46-175Rev1M124, 127A + - - - +/- 4.044 Positive
aColonies were grown on CSM Leu-Trp- and replica plated on CSM Leu-Trp-His- with 12.5, 50, or 100mM 3AT; CSM Leu-Trp-Ura-, and CSM Leu-Trp- with
0.2% %FOA.
bExpression of-galactosidase was qualitatively monitored by using X-gal (not shown) and-galactosidase activity was quantitatively measured with CPRG
assays. The-gal units (BGU) were calculated using the following formula:-gal units = 1,000 x OD574/(t x V x OD600)
where:
t = elapsed time (in minutes) of incubation
V = volume of culture used in the assay (ml)
OD570 = absorbance by chloramphenicol red and light scattering by cell debris
OD600 = cell density at the start of the assay
cThe phenotype was determined by combining the results from growth on the different media and-galactosidase assays.
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Figure 2.3. Helical wheel of the NSP4 Ampathhelix in the NSP4 mutants. Helical wheel schematics
of NSP4 residues 95-135 (A. upper left), NSP4ala (B. upper middle), NSP4HydroMut (C. upper right), the
three revertant (D-F, Rev1, 2, 3, middle panel) and the four other mutants (G-J, NSP4Rev2M116,124,127A,
NSP4Rev2M116A, NSP4Rev1,2M127A, NSP4Rev1M124,127A). Note that the NSP4 sequence contains clearly
delineated hydrophobic (yellow) and charged faces. The charged face contains both acidic (blue) and basic
(green) domains. The disruption of the hydrophobic face is shown in the NSP4HydroMut and alterations of
this face are seen the seven mutants.
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The HIS3 gene was induced as shown with a dose-dependent growth with
increasing levels of 3AT (CSM Leu-Trp-His- + 3AT) (Table 2.1). All test and control
yeast grew with 12.5mM 3AT, but growth on media with 50 and 100mM 3AT
demonstrated little to no growth. The negative and 1+ positive control yeasts had a
reduced amount of growth at 50mM 3AT, but the 2+ positive control showed no growth.
All three clones, NSP446-175, NSP446-175Ala, and NSP446-175HydroMut, failed to grow at 50 or
100mM 3AT (Table 2.1).
The URA3 gene was induced as shown with growth on CSM-Leu-Trp-Ura plates
and with the inhibition of growth on CSM-Leu-Trp + 0.2% 5FOA. The URA3 promoter,
SPO13, previously has been shown to be a weak promoter, producing a very small
amount of yeast growth. Likewise, our data agree with this report as we saw only a small
amount of yeast growth. Growth on the CSM-Leu-Trp-Ura plates demonstrated moderate
and small growth patterns for the 2+ and 1+ positive controls respectively, while
NSP446-175 and NSP446-175Ala showed no growth. NSP4HydroMut showed a very small
amount of growth on the CSM-Leu-Trp-Ura plates. Inhibition of growth on CSM-Leu-Trp
+ 0.2% 5FOA was seen with the 2+ positive control, while both the negative control and
NSP4HydroMut grew well. All the other test colonies, 1+ positive control, NSP446-175 and
NSP446-175Ala had a very small amount of growth on CSM Leu-Trp- + 0.2% 5FOA.
The induction of lacZ gene was indicated with the production of-galactosidase
(-gal) as indicated by the development of a blue color upon addition of substrate X-gal
to yeast grown on nitrocellulose membranes (data not shown). All colonies that were
positive for-gal with the addition of X-gal or demonstrated phenotypes interpreted as
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possible weak interactors using criteria outlined in the Y2H manual were confirmed
using the quantitative chorophenol red--D-galactopyranoside (CPRG) assay for-gal
activity (Table 2.1). The positive controls (2+ and 1+) had 37 and 0.334-galactosidase
units (BGU), respectively. The negative control and NSP446-175HydroMut had 0.134 and
0.105 BGU, respectively, while NSP446-175 and NSP446-175Ala had 1.39, 1.822 BGU,
respectively.
FLNSP4 and FLNSP4Ala Associate With Caveolin-1 in an In Vitro
Peptide Binding Assay
To confirm the yeast two-hybrid results, synthesized caveolin-1 peptides were
bound to sepharose beads and utilized to capture full-length (FL) proteins, i.e., FLNSP4,
FLNSP4Ala, or FLNSP4HydroMut from yeast lysates expressing the respective proteins
(Figure 2.4). Western blot analyses of cell lysates demonstrated no NSP4-specific bands
with sepharose beads only (lanes 1, 2, 3, 4). NSP4-specific bands were observed at ~ 28,
24 and 20kD from FLNSP4 lysates with Cav2-31 (lane 5), whereas FLNSP4Ala
demonstrated only 24 and 20kD bands (lane 6). Likewise a 24kD NSP4-specific band
was shown with both FLNSP4 and FLNSP4Ala with Cav161-178 (lanes 9 and 10). No bands
were detected from FLNSP4HydroMut lysates with either Cav2-31 or Cav161-178 (lane 7 and
11). Yeast lysates without NSP4 plasmids showed no specific binding to either Cav2-31
or Cav161-178 (lane 8 and 12).
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Figure 2.4. Caveolin-1 peptide binding assays with FLNSP4, FLNSP4Ala, and FLNSP4HydroMut..
Western blot analysis of yeast lysates containing expressed full-length- NSP4, -NSP4Ala and -NSP4HydroMut
(FLNSP4, FLNSP4Ala, and FLNSP4HydroMut) and incubated with CNBr-activated sepharose 4B beads with
either N-terminal (Cav2-31), C-terminal (Cav161-178), or no peptide. The beads were washed and bound
proteins were separated by SDS-PAGE, transferred to nitrocellulose membranes for Western blot analysis,
and probed using rabbit anti-NSP4150-175. Control lanes (1-4) show the absence of non-specific binding to
the sepharose beads with all lysates tested. Lanes 5-7 show the reactivity of FLNSP4 and FLNSP4 mutants
to Cav2-31. Only the FLNSP4HydroMut failed to bind the N-terminal caveolin-1 peptide. The same binding
pattern was observed when FLNSP4 and FLNSP4 mutant proteins where incubated with Cav161-178 (lanes
9, 10, and 11). InVSc1 alone showed no NSP4-specific bands using either peptide (lanes 8 and 12).
NSP4 Revertants Bind to Caveolin-1 by Yeast Two-Hybrid Analyses
Since our previous data demonstrate stronger binding of NSP4 to caveolin-1 in
yeast two-hybrid assays when two N-terminal hydrophobic domains are deleted (Parr et
al., 2006), we PCR amplified the 46-175 portion of the full length mutants and cloned
the respective deletion mutants into the entry plasmids. To map the binding of NSP4 to
caveolin-1 to a single amino acid, each of the three mutated hydrophobic amino acids of
NSP446-175HydroMut were separately reverted to produce three additional clones, NSP4Rev 1,
NSP4Rev2, and NSP4Rev3 (Table 2.1, Figures 2.3D, E, and F). The NSP446-175Ala and
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NSP446-175HydroMut and the three revertant clones were transformed into yeast with
caveolin-1. The NSP446-175 NSP446-175HydroMut, NSP4Rev1, NSP4Rev2, NSP4Rev3 clones
grew on CSM-Leu-Trp, CSM-Leu-Trp-His + 12.5mM 3AT, while NSP446-175Ala showed a
reduced amount of growth. Only NSP4Rev2 and NSP4Rev3 demonstrated a reduced amount
of growth on CSM-Leu-Trp-His + 50mM 3AT while NSP446-175, NSP446-175Ala, NSP446-
175HydroMut and NSP4Rev1 demonstrated no growth on CSM-Leu-Trp-His + 50mM 3AT.
None of the five clones grew on CSM-Leu-Trp-His +100mM 3AT (Table 2.1).
No growth was observed on the CSM-Leu-Trp-Ura plates with NSP446-175,
NSP446-175Ala, NSP446-175HydroMut, NSP4Rev1, NSP4Rev2, or the negative control, whereas
NSP4Rev3 demonstrated a very small amount of growth. Inhibition of growth on CSM-
Leu-Trp + 0.2% 5FOA was observed with NSP4Rev3, but NSP446-175, NSP446-175Ala,
NSP4Rev1 and NSP4Rev2 had a very small amount of growth. The negative control and
NSP446-175HydroMut grew well.
-galactosidase activity was measured both qualitatively and quantitatively with
X-gal and CPRG assays, respectively. NSP446-175 and NSP446-175Ala and the three
revertant clones were positive in the X-gal assay, only NSP446-175HydroMut was negative
indicating no-gal activity. The quantitative-gal NSP446-175HydroMut was measured as
0.105 BGU, less than that of the negative control (0.134 BGU) whereas the NSP446-175,
NSP446-175Ala-gal activity was 4-5 times that of the positive control at 1.39 and 1.822
BGU. The quantitative-galactosidase activity of revertants measured significantly
greater than the positive control (Table 2.1). NSP4Rev1, NSP4Rev2, NSP4Rev3 produced
3.941, 3.042, and 3.195 BGU, respectively, which are approximately 20-30 times that of
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the negative control (0.134 BGU) and 10 times of that the 1+ positive control
(0.334BGU).
Binding of NSP4 Alanine Mutants NSP4 to Caveolin-1
Four additional mutants, NSP4Rev2M116, 124, 127A, NSP4Rev2M116A, NSP4Rev1, 2M127A,
and NSP4Rev1M124, 127A (Figure 2.3G-J), were made to further delineate the amino acid
sequence necessary for caveolin-1 binding. The four clones were transformed into
InVSc1 with caveolin-1 and grown on CSM-Leu-Trp, CSM-Leu-Trp-His + 12.5mM 3AT,
however NSP4Rev2M116, 124, 127A and NSP4Rev1, 2M127A, demonstrated a reduced amount of
growth on CSM-Leu-Trp-His + 50 mM 3AT while NSP4Rev2M116A and NSP4Rev1M124, 127A
demonstrated no growth. None of the clones grew on CSM-Leu-Trp-His +100mM 3AT
(Table 2.1).
No growth was observed on the CSM-Leu-Trp-Ura plates with NSP4Rev2M116A,
NSP4Rev1, 2M127A, and NSP4Rev1M124, 127A, while the NSP4Rev2M116, 124, 127A demonstrated a
very small amount of growth. All four of the clone exhibited a small amount of growth
on CSM Leu-Trp- + 0.2% 5FOA.
-galactosidase activity was measured both qualitatively and quantitatively with
X-gal and CPRG assays, respectively. The four clones were qualitatively positive when
treated with the X-gal substrate. The NSP4Rev2M116, 124, 127A and NSP4Rev2M116A had-gal
activity of 0.056 and 0.165 BGU, the former being less than half of that of the negative
control and the latter only slightly greater than the negative control. NSP4Rev1, 2M127A and
NSP4Rev1M124, 127A demonstrated quantitative amounts of-gal activity greater than the
positive control, 2.581 and 4.044 BGU respectively (Table 2.1). Similar to the
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revertants, these-gal activities are approximately 20-30 times that of the negative
control (0.134 BGU) and 10 times of that the 1+ positive control (0.334BGU).
NSP4Rev1, NSP4Rev2, NSP4Rev3, NSP4 Rev1,2 M127A, and NSP4 Rev1,2 M124, 127A Associate With
N-terminal and C-terminal Caveolin-1 Peptides In Vitro, While NSP446-175HydroMut,
NSP4Rev2 M 116A, 124A, 127A and NSP4Rev2 M116A Do Not
To confirm the data of the yeast two-hybrid assay, caveolin-1 peptides (Cav2-31,
Cav19-40, Cav76-101, and Cav161-178) were bound to sepharose beads and tested for binding
to the NSP4 mutants. No bands were observed from yeast lysates that did not express
NSP4 mutant proteins (InVSc1) (Figure 2.5A, lanes 8 and 12; Figure 2.5B, lane 7; and
Figure 2.4C, lane 7). Western blot analyses of mutant-derived proteins that were
incubated with sepharose beads only demonstrated no bands (Figure 2.5A, lanes 2-4;
Figure 2.5B, lanes 2-7). No NSP4-specific bands were present when the lysates from
NSP446-175, NSP446-175Ala, NSP4Rev1, NSP4Rev2, and NSP4Rev3 were incubated with CSD
Cav76-101 peptide (data not shown). Similarly, no bands were evident in Western blot
analyses of cell lysates from NSP4Rev1, NSP4Rev2 M 116A, 124A, 127A, NSP4Rev2 M116A, NSP4
Rev1,2 M127A, NSP4 Rev1,2 M124, 127A and NSP446-175HydroMut that were incubated with
Sepharose beads with bound CSD Cav76-101 peptide (Figure 2.5B, lanes 8-13).
Additionally, no NSP4 specific bands were detected by Western blot analysis of cell
lysates derived from the NSP4Rev2 M 116A, 124A, 127A, NSP4Rev2 M116A and NSP446-175HydroMut
incubated with Cav19-40 and Cav161-178 (Figure 2.5C, lanes 2, 3, 6; lanes 9, 10, 13).
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A.
Figure 2.5. Caveolin-1 peptide binding assays of NSP4 mutants. A. Western blot analyses of yeast
lysates expressing NSP4Rev1, NSP4Rev2, and Rev3 and incubated with CNBr-activated sepharose 4B beads
with Cav2-22, Cav161- 178 or no peptide. The beads were washed, separated by SDS-PAGE, and the peptide-
bound proteins were detected by Western blot using rabbit anti-NSP4150-175. InVSc1 alone showed no
NSP4-specific bands using either peptide (lanes 1and 8). Control lanes (1-4) show the absence of non-
specific binding to the sepharose beads with revertant yeast cell lysates. Lanes 5, 6, and 7 indicate that all
three revertant NSP4 proteins bound to the N-terminal peptide, Cav2-32. The same binding pattern was
observed with the C-terminal peptide, Cav161-178 (lanes 9, 10, and 11). B. Western blot analysis of yeast
lysates containing expressed NSP4Rev2, NSP4Rev2 M 116A, 124A, 127A, NSP4Rev2 M116A, NSP4 Rev1,2 M127A,NSP4
Rev1,2 M124, 127A and NSP446-175HydroMut and incubated with CNBr-activated sepharose 4B beads with either no
peptide or CSD peptide (Cav76-101). The beads were washed and bound proteins were separated by SDS-
PAGE, transferred to nitrocellulose membranes for Western blot analysis, and probed using rabbit anti-
NSP4150- 175. InVSc1 alone showed no NSP4-specific bands using either the beads or the peptide (lane 7).
Control lanes (1-6) show the absence of non-specific binding to the sepharose beads with all yeast cell
lysates tested. Similarly, lanes 8-13 show no binding between Cav76-101 and any of the yeast cell lysates
tested.
B.
8 9 10 11 12 13 14 15
InVSc1 - - - - - - + - - - - - - + -
Rev2 + - - - - - - + - - - - - - -
Rev2M116, 124, 127A - + - - - - - - + - - - - - -
Rev2M116A - - + - - - - - - + - - - - -
Rev1, 2M127A - - - + - - - - - - + - - - -
Rev1,2M124, 127A - - - - + - - - - - - + - - -
NSP4 46-175Hydo - - - - - + - - - - - - + - -
RV Positive Control - - - - - - - - - - - - - - +
No Peptide Cav 76-101 Positive
1 2 3 4 5 6 7
CNBr-activated Sepharose4B
No peptide Cav 22-31 Cav 161-178__
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C.
Figure 2.5. Caveolin-1 peptide binding assays of NSP4 mutants, continued. C. Western blot analysis of
yeast lysates containing expressed NSP4Rev2, NSP4Rev2 M 116A, 124A, 127A, NSP4Rev2 M116A, NSP4 Rev1,2
M127A,NSP4 Rev1,2 M124, 127A and NSP446-175HydroMut and incubated with CNBr-activated sepharose 4B beads
with either N-terminal (Cav19-40) or C-terminal (Cav161- 178). InVSc1 alone did not bind the N-terminal
peptide, Cav19-40 peptide. Lanes 1, 4, and 5 indicate that NSP4Rev2, NSP4 Rev1,2 M127A, NSP4 Rev1,2 M124, 127A
bound to the N-terminal, Cav19-40. The same binding pattern was observed with the C-terminal peptide,
Cav161-178 (lanes 8, 11, and 12). NSP446-175HydroMut, NSP4Rev2 M 116A, 124A, 127A, nor NSP4Rev2 M116A bound
either the N-terminal (lanes 2, 3, 6) or the C-terminal (lanes 9, 10, and 13) caveilin-1 peptides. RV-
infected cell lysates were used a positive control.
Only in the Western blot analyses of NSP4Rev1, NSP4Rev2, NSP4Rev3, NSP4 Rev1,2
M127A, and NSP4 Rev1,2 M124, 127A were NSP4-specific bands was observed. The NSP4
specific band of ~17kD was observed in the three revertants with both Cav2-31 and
Cav161-178 (Figure 2.5A lanes 5, 6, 7 and 9, 10, 11, respectively). Cell lysates derived
from mutants NSP4 Rev1,2 M127A, and NSP4 Rev1,2 M124, 127A that were incubated with Cav19-
40 and Cav161-178 demonstrated typical NSP4 bands (Figure 2.5C, lanes 4 and 5; lanes 11,
12). When bound to Cav19-40 both mutants exhibited a multimer ~40kD, however NSP4
Rev1,2 M124, 127A also exhibited multimers of 48kD.
8 9 10 11 12 13 14 15
Cav19-40
19-40
Cav161-178
1 2 3 4 5 6 7
InVSc1 - - - - - - + - - - - - - + -
Rev2 + - - - - - - + - - - - - - -
Rev2M116, 124, 127A - + - - - - - - + - - - - - -
Rev2M116A - - + - - - - - - + - - - - -
Rev1, 2M127A - - - + - - - - - - + - - - -
Rev1,2M124, 127A - - - - + - - - - - - + - - -
NSP4 46-175Hydo - - - - - + - - - - - - + - -
RV Positive Control - - - - - - - - - - - - - - +
Positive
Control
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FLNSP4HydroMut Is Glycosylated When Expressed in Yeast
To determine if the multiple NSP4-specific bands from FLNSP4HydroMut
represented the same glycosylation pattern as that observed in RV-infected mammalian
cells (Parr et al., 2006) and to ensure the lack of binding to the Cav2-31, Cav19-40, and
Cav161-178 was not due to an altered glycosylation pattern, yeast lysates were digested
with Endo H and evaluated by Western blot analysis (Figure 2.6). The mock treated
FLNSP4HydroMut (lane 1) demonstrated proteins ~28, 24, 20 and 17 kD, and with the
addition of EndoH decreased to mostly 20kD with the same amount of a 17kD protein
(lane 2). The RV-infected MDCK cell lysates showed a possible dimer ~56kD, and a
monomer ~28kD that were both decreased to ~40kD and 20kD respectively with the
addition of EndoH (lanes 3 and 4). These data verify that the glycosylation in the yeast
was equivalent to that observed in mammalian cells and not responsible for the lack of
binding.
Figure 2.6. FLNSP4HydroMut is glycosylated when expressed in yeast. To discern if the 28 and 24kD
bands correspond to the singly- and doubly-glycosylated forms seen in mammalian cells, yeast expressing
FLNSP4HydroMut and RV-infected MDCK lysates were Endo H digested and compared by Western blot
analyses using rabbit anti-NSP4150-175. Lanes 1 and 3 correspond to the mock digested lysates, whereas
lanes 2 and 4 represent the Endo H digested yeast and MDCK cell lysates, respectively. Lane 5 diaplays
the glycosylation of NSP4.
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Modification of the Hydrophobic Face of the NSP4 AAH Does Not Necessarily
Abrogate Binding to Caveolin-1
Binding of caveolin-1 to the NSP4 enterotoxic domain is through the
hydrophobic face of the AAH. Our study demonstrates NSP4 is able to bind caveolin-1
even when some of the hydrophobic residues are mutated. By using the remaining
hydrophobic residues putative hydrophobic binding faces are able to form. Table 2.2
shows the mutation in the hydrophobic aa residues in the hydrophobic face and the
hydrophobic aa residues available to form potential putative hydrophobic binding faces.
Two hydrophobic planes can be defined using multiples of 3.5 turns on the AAH that
bring individual hydrophobic/aromatic aa into alignment and include (a) Plane A I113-
V124-Y131D and (b) Plane B L116-L127-L134 (Table 2.2).
Five possible hydrophobic binding faces have been identified from the
hydrophobic planes NSP4 mutants: (a) Rev1: Plane A--I113 and Plane B--L116, L127,
L134; (b) Rev 2: Plane A--V124 and Plane B--L116, L127, L134; (c) Rev 3: Plane A--
Y131 and Plane B--L116, L127, L134; (d) Rev1, 2 M127A: Plane A--I113, V124 and
Plane B--L116, L134; and (e) Rev1 M124, 127 A: Plane A--I113 and Plane B--L116,
L134.
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1 Orange indicates charged aa (R, K, or D.)
2 Green indicates alanine.
3 Blue denotes the hydrophobic plane on the left side of the 3-D image of the AAH of NSP4.
4 Red denotes the hydrophobic plane on the right side of the 4-D image of the AAH of NSP4.
Discussion
We have previously shown the enterotoxic domain of NSP4, residues 114-135,
binds to caveolin-1, the defining structural protein of caveolae (Thomas and Smart,
Table 2.2 Hydrophobic plane mutations and intact hydrophobic aa residue available to
form a modified hydrophobic face that binds caveolin-1
Mutant Binding
Hydrophobic Planes Mutations
Hydrophobic/Aromatic aa
Available for
Binding
Each Plane
A (left) B (right)
I113
V124
Y131
L116
L127
L134
Charged
aa
Alanine Charged
aa
Alanine A B
Rev 1
Rev 2
Rev 3
Rev 1, 2 M127A
Rev 1 M124, 127A
Rev 2 M116A
Rev 2 M116, 124,
127A
HydroMut
Positive
Positive
Positive
Positive
Positive
Negative
Negative
Negative
21
V124K
Y131D
2
I113R
Y131D
2
1113K
V124K
1
Y131D
1
Y131D
2
I113R
Y131D
2
I113R
Y131D
3
I116R
V124K
Y131D
--
--
--
--
12
L124A
--
1
V124A
--
--
--
--
--
--
--
--
--
--
--
--
--
1
127A
1
1127A
1
L116A
2
L116A
L127A
--
13
I113
1
V124
1
1131
2
L113
V124
1
I113
1
V124
0
0
34
I116
L127
L134
3
I116
L127
L134
3
I116
LI27
L 134
2
1116
L134
2
1116
1.134
2
LI27
L134
1
L134
3
1116
L127
L134
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2008; Parr et al., 2006; Spisni et al., 2005). To dissect the precise NSP4 binding domain,
six charged amino acids (aas) in the polar face of the AAH of FLNSP4 (Figure 2.7A)
were changed to alanine by site-directed mutagenesis (FLNSP4Ala, Figure 2.7B). Three
specific hydrophobic residues within the hydrophobic face of FLNSP4 were replaced
with charged aas in the AAH (FLNSP4HydroMut, Figure 2.7C). FLNSP4Ala bound
caveolin-1 in the Y2H, CPRG and peptide binding assays equivalent to wild type, but
disruption of hydrophobic in FLNSP4HydroMut abrogated the binding to caveolin-1. These
data strongly suggest the protein-protein interaction between NSP4 and caveolin-1
occurs through the hydrophobic face of the AAH.
In this study, we further mapped the hydrophobic residues of NSP4 responsible
for caveolin-1 binding by reverting the individual charged residues of NSP4HydroMut
(Figure 2.8A) back to the original hydrophobic aa. The three revertant mutants (Rev 1, 2,
and 3; Figure 2.8B-D), regained caveolin-1 binding. Further analysis of the three
revertants reveled residues that could form hydrophobic binding sites (Figure 2.3D-F
and Figure 2.8B-D). The hydrophobic face of each revertant is disrupted by two charged
aa residues not 3 as in NSP4HydroMut.
The putative hydrophobic binding site for Rev1 contains aa residues I113, L116,
L127, and L134. Whereas, caveolin-1 binding to Rev2 appears to depend on aa L116,
V124, L127, and L134, while Rev 3 binding to caveolin-1 seems to be contingent on aa
L116, L127, and Y131 or L134. All three revertants have three aas, L116, L127, and
L134 in common in the theoretical binding sites (Figure 2.8B-D). Protein-protein
interactions not only rely on the recognition of specific aa motifs, but also may depend
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upon their exposure at the surface of the protein, the environment of the aa residues, or
may bind conformationally-dependent epitopes (Couet et al., 1997a). For example, the
putative hydrophobic face of L116, L127, and L134 is present in NSP4HydroMut (Figure
2.8A); however, it does not bind caveolin-1 either because of conformational constraints
or possibility due to repulsion by charged aas. This specificity of conformation is
demonstrated by transmembrane envelope glycoprotein of some HIV-1 viruses that
interact with caveolin-1. For example, the highly conserved CBD1 but not CBD2 in the
transmembrane envelope glycoprotein of some HIV-1 viruses can adopt a defined
secondary structure and bind the CSD of caveolin-1 (Benferhat et al., 2008).
A. B. C.
Figure 2.7. Three-dimensional of the NSP4 alanine and hydrophobic mutants of the AAH. A.
NSP4, B. NSP4Ala generated by replacing charged aa with alanine: D114A, K115A, R119A, E125A,
D132A, and K133A, and C. NSP4HydroMut was generated by site-directed mutagenesis to replace three
specific hydrophobic residues with charged aas: I113R, V124K, and Y131D.
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A. B. C. D.
Figure 2.8. Three-dimensional of the NSP4 Rev 1, Rev, 2, and Rev 3. A: HydroMut. B. In Rev1
the I113R was reverted to I113. C: In Rev2 the V124K was reverted to V124. D: In Rev 3 the
Y131D was reverted to Y131. In each case the Rev mutants contain one hydrophobic or aromatic
aa in the left plane (blue boxes) and three hydrophobic aa in the right plane (red boxes).
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A panel of four alanine NSP4 hydrophobic mutants was constructed to further
localize the specific NSP4-caveolin-1 binding site. Alanine was used to minimize
conformational and structural disruption of the hydrophobic face of the AAH allowing
for the identification of specific aas that are required for binding caveolin-1. In Rev1, 2
M127A and Rev1 M124, 127A the hydrophobic face was altered by a charged residue
and one or two alanine residues; however, binding to caveolin-1 is retained (Figure 2.9A
and B). Both mutants bind caveolin-1 and 3D analyses demonstrate a potential
hydrophobic binding site that includes aa residues I113, L116, and L134 (Figure 2.9C
and D) that is present in Rev1 as describe above.
Rev2 M116, 124, 127A (Figure 2.9D) does not bind caveolin-1, indicating that
there are insufficient hydrophobic residues to form a hydrophobic face. Likewise,
Rev2M116A (Figure 2.9C), does not bind caveolin-1. The only difference between this
mutant and Rev2, which does bind caveolin-1, is the replacement of L116 by an alanine
residue. Additionally, neither of these two non-binding mutants appear to retain one of
the above described putative hydrophobic faces present in the Rev mutants. These data
strongly suggest that L116 is pivotal to binding NSP4 to caveolin-1.
Additionally, peptides to both the N- and C-terminus of caveolin-1, residues 2-31
or 19-40 and 161-178, respectively, bind NSP4, NSP4Ala, the three revertant clones,
NSP4Rev1,2M127, NSP4Rev1M124, 127A, but not NSP4HydroMut, NSP4Rev2M116, 124, 127A, or
NSP4Rev2M116A supporting the yeast two-hybrid results. There was no binding between
any of the tested wild type and mutant NSP4 proteins and the caveolin-1 peptide
residues 76-101. These results complement the results shown by Mir et al. (2007), which
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mapped the NSP4 binding site to both the N- and C-terminus of caveolin-1. Taken
together, these data strongly suggest that NSP4 binds the N- and C-termini of caveolin-
1via the hydrophobic face, and that conformation and structure of both molecules are
important for binding.
A. B. C. D.
Figure 2.9. Three-dimensional of the NSP4 alanine mutants. A: In Rev1, 2 M127A, I113R was
reverted to I113, V124D was reverted to V124, and L127 was replaced with alanine. B: In Rev1 M124,
127 A, I113R was reverted to I113, V124K and L127A were replaced with alanines. Both A and B
bound caveolin-1. C: In Rev2 M116A, V124D was reverted to V124 and l116 was replaced with
alanine. D. In Rev 2 M116, 127, 127A, V124D, L116, and L127 were replaced with alanines. Both C
and D failed to bind caveolin-1. Blue boxes indicate hydrophobic aa in the left plane and red boxes
indicate hydrophobic aa in the right plane.
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These data indicated that the NSP4 binding face includes hydrophobic aa
residues I113, L116, V124, L127, L134 and the possibly aromatic residue Y131 as
shown in the helical wheel depiction (Figure 2.3A and 2.7A). The tyrosine residue at
position 131 is located in the face as the assumed NSP4-caveolin-1 binding face and
functions diarrhea induction. The tyrosine appears not to be required for caveolin-1
binding as both Rev 1 and Rev 2 bind caveolin-1 in the absence of Y131. Reverting the
charged Y131D to Y131 in Rev 3 does reconstitute its caveolin-1 binding. It is possible
that in the absence of the charged aa at the position 131, the mutant assumes a
conformation more like wild type NSP4 making the hydrophobic aas more available to
bind caveolin-1.
Peptide binding assays have indicated that the caveolin-1 binding domain in
NSP4 is localized the aa residues 114-135 (Parr et al., 2006), that is I113 is not part of
the binding domain. However, the binding domain defined by Y2H does include I113. It
may be that I113 is recruited to reinforce and stabilize the binding between the mutants
and caveolin-1.
From these data, we can identify a NSP4-caveolin-1 binding motif of113L116124
127131134 whereis hydrophobic,is aromatic, and L is leucine. The five potential
hydrophobic binding configurations that are contained in this binding motif can be
generated: (1) I113, L116, L127; (2) L116, V124, L127; (3) L116, L127, Y131; (4) I113,
L116, V124; and (5) I113, L116, L134. Our data indicate L116 is critical for NSP4-
caveolin-1 binding as it occurs in all hydrophobic faces; however, it is unclear if L134 is
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required for binding. Rev 1, Rev 2, Rev 3, R1,2 M127A, and Rev1 M124, 127A bind
caveolin-1 and contain both L116 and L134.
The specificity of NSP4-caveolin-1 interaction with short binding motifs is not
unique. A 20-amino acid region of the cytosolic amino terminus of the caveolin-1
scaffolding domain (CSD) has been shown to mediate interactions with signaling
molecules such as G-proteins, Src-like kinases, Ras, and others (Couet et al., 1997b;
Dubroca et al., 2007; Li et al., 1995, 1996; Razani et al., 2001; Song et al., 1996;
Stahlhut and van Deurs, 2000). Couet et al. (1997a) used random peptide ligands from
phage display libraries to examine the nature of the interaction between G-proteins
subunits and Gi2, a known caveolin-1 interacting protein and caveolin-1. They showed
that the interaction was strictly dependent a short peptide sequence (XXXXXor
XXXXXX, where is an aromatic residues W, F, or Y) containing aromatic residues
as replacement of critical phenylalanine residues with glycine or alanine abrogated the
interaction. A sequence of four aa residues (92FTVT95) within the CSD are strictly
required for Gi2binding to caveolin-1. Numerous other caveolae-associated proteins
(intracellular signal transducers, e.g., Src-like kinases, eNOS, MAP kinase, growth
factors, and others) contain cytoplasmically accessible sequences that are reminiscent of
the G i2binding sequence (Lisanti et al., 1994; Sargiacomo et al., 1993; 1996; Smart et
al., 1995). These data suggest that short aa sequences do facilitate protein-caveolin-1
binding. In fact, Song et al. (1996) found that a single amino acid change prevents the
interaction between Ras and caveolin-1.
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Viral proteins are known to mimic cellular functions to take over cellular
processes. The possible use of caveolin-1 by RV NSP4 to traffic within the cell is not
unique. The HIV-1 gp41 has been shown to contain a putative caveolin-1 binding motif
(XXXXX) that is like that of Gi2(Huang et al., 2007) and may be involved
endocytosis of this virus. Additionally, caveolin-1 has been shown to function in
locating the matrix protein (MA) of Gag precursor of murine leukemia virus to the PM
via a caveolin-1 binding domain (CBD) within the N-terminus of the MA. This CBD is
highly conserved among other-retroviruses suggesting that this class of viruses may
use the MA-caveolin-1 interaction to traffic to the PM similar to that of the RV NSP4-
caveolin-1 interaction (Yu et al., 2006).
Our data show that three hydrophobic aa are needed for NSP4 to bind to
caveolin-1 and at least one hydrophobic mutant must reside in Plane A and at least two
must reside in Plane B one of which must be L116 (Table 2.3). For example, Rev 1M
124, 127A demonstrates this minimum binding requirement. Rev 1, Rev 2, Rev 3, and
Rev 1,2 M127A exceed the minimum requirement by having 4 aa available for binding.
Rev2 M116A possesses 3 hydrophobic aas available for binding, but not L116, whereas
Rev 2 M116, 124, 127 A only has one hydrophobic aa available for binding; therefore,
these mutants do not bind caveolin-1. HydroMut has the requisite 3 hydrophobic and the
L116, but does not have a hydrophobic aa in Plane A available for binding; hence, it
does not bind caveolin-1.
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Table 2.3. Hydrophobic plane mutations and modified hydrophobic faces
Mutant
Hydrophobic Planes
A B
Rev 1 I113 L116
L127
L134
Rev 2 V124 L116
L127
L134
Rev 3 Y131 L116
L127
L134
Rev 1, 2 M127A I113
V124
L116
L134
Rev 1M 124, 127A I113 L116
L134
Rev 2 M116A V124 L127
L134
Rev 2 M116, 124, 127 A -- L134
HydroMut -- L116
L127
L134
Our data suggest: (a) NSP4 binds caveolin-1 via an interaction with hydrophobic
face of the NSP4 AAH; (b) the NSP4-caveolin-1 interaction is specific in that it requires
one hydrophobic aa in the left plane and two hydrophobic aas in the right plane, one of
which must be L116; (c) both the N- or the C-terminus of caveolin-1 can function as the
accepting substrate for the NSP4, which may result in different biological outcomes; (d)
the presence of the binding motif is not sufficient to facilitate binding, binding of NSP4
to caveolin-1 may be conformational specific, as the HydroMut contains the critical aa
and surrounding hydrophobic residues but does not bind caveolin-1, maybe due to
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apparent conformational changes caused by the presence of the charged residues; (e)
NSP4 may use the caveolin-1 interaction to traffic to the PM, analogous to -
retroviruses. The requisite for hydrophobic aa in each plane of the NSP4 AAH might
play a role in NSP4 binding both the C- and N-termini. Since both NSP4 and caveolin-1
form multimers, different NSP4 planes could be exposed for binding. The caveolin-1
termini may fold around the NSP4 such that each terminus binds a different face of a
different monomer of the multimer.
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CHAPTER III
ROTAVIRUS NSP4 EXPRESSION AND TRANSPORT IN THE
ABSENCE OF OTHER VIRAL PROTEINS
Overview
In RV-infected cells, NSP4 was shown to transport from the ER to the PM by a
Golgi-bypassing pathway (Gibbons, 2007). The focus of this study was to determine if
transfected NSP4, in the absence of other viral proteins, traffics similarly to NSP4
expressed in infected cells. We showed that full-length, endoH-sensitive NSP4 was
exposed on the exofacial surface of intact kidney-derived MDCK epithelial cells at 7
hours post infection. To begin to dissect those residues that contribute to NSP4 transport
and exposure on the cell surface, Baby Hamster Kidney (BHK) cells were transfected
with full-length NSP4 FLNSP41-175Alanine NSP41-175Hydrophobic (FLNSP4Hydro) plasmid
DNA, surface biotinylated, and examined by IFA or Western blot at 20 h post
transfection. Our results revealed FLNSP4 and FLNSP4Ala were expressed and exposed
on the surface of BHK cells in the absence of other viral proteins, whereas FLNSP4Hydro
was not observed at the cell surface. The expression of NSP4 in the absence of other
viral proteins does not appear to interfere with ability to traffic in the cell.
NSP4-transfected cells also were used to determine if additional viral proteins
were required for the intracellular NSP4-caveolin-1 association by epifluorescence. In
the absence of other viral proteins, transfected NSP4 colocalized with caveolin-1 similar
to that observed in RV-infected cells. These results confirmed that the NSP4 protein is
sufficient in and of itself to associate with the key caveolar structural protein caveolin-1
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in two different cell types. NSP4 expression was sufficient for redistribution and
colocalization of the caveolin-1 chaperone complex proteins, cyclophilin A, cyclophilin
40, and HSP56 as seen in RV-infected cells. The data presented here suggest NSP4
expression alone does not hinder its intracellular transport or its interaction with
caveolin-1. The toxin traffics to the PM, binds and co-localizes with caveolin-1, and
redistributes the caveolin-1 chaperone complex proteins in the absence of any other viral
proteins.
Introduction
Rotavirus (RV) NSP4 viral enterotoxin and the enterotoxic peptide, amino acids
(aa) 114-135, have been shown to induce diarrhea in young mice by promoting Cl-
secretory currents via a calcium-mediated pathway in the absence of histological
alterations (Ball et al., 1996; Mebus, 1989; Osborne et al., 1988). NSP4, initially
identified as an endoplasmic reticulum (ER) resident glycoprotein, plays a critical role in
viral morphogenesis and performs an important regulatory role in the morphogenesis of
the transcriptionally active double-layered particles to triple-layered particles (Au et al.,
1989; Bergmann et al., 1989; Pesavento et al., 2006; Taylor et al., 1992, 1996).
A C-terminal fragment of NSP4 (residues 112-175) has been identified in the
culture media RV-infected epithelial cells (Zhang et al. 2000). Additionally, a 32 kD,
partially endo-H resistant NSP4 species has been identified in culture media of RV-
infected Caco-2 cells (Bugarcic and Taylor, 2006). These data indicate at least a portion
of NSP4 leaves the ER. Subsequent studies confirm the presence of NSP4 at multiple
locations in RV-infected cells (Berkova et al., 2006; Boshuizen et al., 2004; Cuadras and
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Greenberg, 2003; Parr et al., 2006; Xu et al., 2000). In addition, co-localization with
caveolin-1 places NSP4 in the cytosol and at the cell periphery (Parr et al., 2006). These
data confirm NSP4 is found throughout the cell and is released from the cell.
Similarly, caveolin-1 exists in a number of pools within the cell and occurs as an
integral membrane protein as well as a soluble protein. Caveolin-1 is found in the
intestine, interacts with cholesterol, and functions to transport de novo synthesized
cholesterol to and from the ER and PM caveolae. It functions in organizing signaling of
the cell surface molecules, including those involved in calcium homeostasis (Cheng et
al., 2006; Field et al., 1998; Hailstones et al., 1998). The integral membrane pool of
caveolin-1 traffics via the secretory pathway, which travels through the Golgi complex
in the classical secretory pathway (Bergmann et al., 1989; Bugarcic and Taylor, 2006).
The cytosolic pool of caveolin-1 has been reported to associate with cyclophilin 40,
cyclophilin A, and heat shock protein 56 (Uittenbogaard et al., 1998); however, a
separate laboratory has not confirmed these studies.
Both caveolin-1 and NSP4 function as integral membrane proteins and as soluble
proteins, occur at multiple sites within the cell, and are multifunctional. Caveolin-1 is a
likely candidate to facilitate the trafficking of NSP4 within the cell.
Using a novel raft isolation technique, FLNSP4 has been shown to traffic to the
PM (Storey et al., 2007) and has been shown to be exposed on the exofacial leaflet of the
PM by surface biotinylation followed by western blot analyses or by FRET analyses
(Gibbons, 2007). The NSP4-caveolin-1 association as well as the association of NSP4
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with the caveolin-1 chaperone complex (CCC) proteins was resolved to 10-nm radius by
FRET analyses (Gibbons, 2007; Storey et al., 2007).
The goal of this study was to determine if FLNSP4, FL NSP4Ala, and
FLNSP4Hydro) transfected into mammalian cells traffic similarly to NSP4 in RV-infected
mammalian cells in the absence of other viral proteins. We used surface biotinylation
and epifluorescence microscopy techniques to determine the exofacial expression of
transfected NSP4 and NSP4 mutants, as well as their association with caveolin-1 and
caveolin-1 chaperone complex proteins.
Materials and Methods
Antibodies and Reagents
Antibodies were generated in rabbits and mice to NSP4 residues 150-175 and
used as primary antibodies in Western blot assays as previously described (Parr and Ball,
2003; Parr et al., 2006; Zhou et al., 2004). Antibodies directed against
Sodium/Potassium ATPase (mouse anti-Na/KATPase, Affinity BioReagents, Golden,
CO), horseradish peroxidase (HRP: goat anti-rabbit immunoglobulin G, Pierce
Biotechnology, Rockford, IL) and Immunofluorescence Assay (IFA) reagents (goat anti-
rabbit Cy2, Streptavidin Cy5, and goat anti-mouse IgG Texas Red (Rockland
Immunochem, Inc., Gilbertsville, PA) were purchased commercially. Hoechst 33342
was used to visualize the nuclei to verify the presence of cells.
Micro bicinchoninic acid (BCA) protein assay (Pierce Biotechnology, Rockford,
IL) was used to quantify protein concentrations with bovine serum albumin standards
according to the manufacturer’s protocol. Lipofectamine 2000™ transfection reagent
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(Invitrogen, Carlsbad, CA) and Amaxa Nucleofection Solution L were used for transient
transfection of the baby hamster kidney-21 (BHK-21) cells with NSP4 or mutant NSP4
plasmid DNA. To distinguish cell surface proteins, surface biotinylation was
accomplished using 0.5mg/ml of membrane impermeable Sulfo-NHS-SS Biotin (Pierce
Biotechnology, Rockford, IL).
Cultured Cells
BHK-21 cells were obtained from ATCC (Rockville, MD) and were maintained
in Minimal Essential Medium (MEM; Mediatech, Inc., Herndon, VA) supplemented
with 5% fetal bovine serum, and 5% Serum Supreme, (Cambrex, East Rutherford, NJ),
10% tryptose phosphate broth, 2 mM L-glutamine (Biowhittaker/Cambrex), 1mM
sodium pyruvate (Cambrex, East Rutherford, NJ), 0.1 mM non-essential amino acids
(Mediatech, Inc., Herndon, VA); 100 U/L penicillin, 100 g/L streptomycin, 0.25g/L
amphotericin (10,000 U p enicillin- 10,000 U of streptomycin- 25g/liter amphotericin
B; Cambrex, East Rutherford, NJ), 26.1 mM sodium bicarbonate (GIBCO, Grand Island,
NY), and 10mM HEPES (Amresco, Solon, OH), pH adjusted to 7.3 ± 0.1, and incubated
at 37oC in 5% CO2. Madin-Darby Canine Kidney cells (MDCK, American Type Culture
Collection, Manassas, VA) were grown in Dulbecco’s Modification of Eagle’s media
(DMEM) supplemented as above and incubated at 37oC in 5% CO2. The transient
transfections were performed according to the manufacturer’s protocol in OptiMeM®
Reduced Serum Medium modification of MEM (Gibco, Grand Island, NY)
supplemented as above without FBS, serum supreme, or antibiotics, the pH adjusted to
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7.3 ± 0.1, and hereafter called transfection media. Transfected cells were maintained in
OptiMeM® supplemented as above without antibiotics at 37oC in 5% CO2.
Transfection
Lipofectamine 2000™
The day before transfection, the BHK cells were washed with PBS three times,
trypsinized for 5 minutes with trypsin-versine at 37oC in 5% CO2. The cells were diluted
in 5 mls of MEM, transferred to a 15 ml conical tube, and pelleted for 10 minutes at
1000 rpm. The supernatant was discarded and the cells re-suspended in 5 mls
maintenance media and counted with a hemacytometer. The cells were plated in 6-well
culture plates at a density of 1.0 x 105 cells per well in 2 mls of their normal growth
medium without antibiotics such that they were ~70% confluent on the day of
transfection. For each well of the 6-well plate that was transfected, 8 µg of
pcDNA3.2Dest NSP41-175, pcDNA3.2Dest NSP41-175Alanine , or pcDNA3.2Dest NSP41-
175Hydrophobic plasmid DNA were diluted in 250 µl of transfection media, added to 10 µl of
Lipofectamine 2000™ transfection reagent in 240 µl transfection media, and incubated
for 20 minutes (to allow DNA-LF2000™ Reagent complexes to form). The growth
media was removed from the cells, the cells were washed two times with 0.5 ml of the
transfection media, and the DNA-LF2000 Reagent complexes (500 µl) were added
directly to each well of cells. The samples were mixed gently by continuous and
incubated at 37°C in 5 % CO2 for 4 hours after which 1.5 mls of MEM growth media
without antibiotics were added, and incubated at 37°C in 5 % CO2 for 20 hours.
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Nucleofection
BHK-21 cells were transiently transfected with pcDNA3.2Dest NSP41-175
plasmid DNA using nucleofection, which delivers the DNA directly into the nuclei of
the cells. The Amaxa Nucleofector II® and Nucleofector I® kits were used following the
protocols designed by Amaxa Biosystems (Cologne, Germany). The cells were grown to
60-70 % confluency (~2 x 106/cm2), harvested, and counted. BHK-21 (1 x 106 cells) in
100l transfection media were mixed with 100l of cell-type specific Nucleofector
solution L and 2 g NSP41-175 plasmid DNA, nucleofected using Nucleofector program
A-031 and plated on 10 mm cover slips and incubated at 37°C in 5 % CO2 for 20 hours.
Western Blot Analyses
Equal amounts of total protein as assessed by BCA were resolved on 12%
polyacrylamide minigels and transferred to nitrocellulose filters (0.45pure
nitrocellulose; GE Osmonics) according to the manufacturer protocol (Mini-PROTEAN
II and Trans-Blot respectively; BioRad). The filters were blocked in 10% Blotto (wt/vol
non-fat dry milk in PBS) for 2 hours at room temperature (RT) with rocking and then
reacted with the primary antibody in 2.5% Blotto overnight (~14 hours) at 4oC with
rocking. The filters were incubated an additional 1 hour at RT with the primary
antibody, then washed once in PBS, twice in PBS with 0.05% Tween-20, and once in
PBS with rocking (10 min per wash). Secondary antibodies were diluted in 2.5% Blotto
and incubated with the filters for 30 minutes at RT with rocking. The nitrocellulose
filters were washed as above, and reacted with Immobilon Western chemiluminescent
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substrates as per the manufacturer’s protocols (Millipore, Billerica MA). The marker-
specific bands were visualized by exposure to and development of x-ray film.
Surface Biotinylation for Isolation of Cell Surface Proteins
Mock and transfected cells were grown in 12-well culture plates for 20 hours,
rinsed with ice cold filter sterilized PBS with 0.1mM CaCl2 and 1mM MgCl2 (PBS-CM),
and then reacted with 0.5mg/ml of membrane impermeable Sulfo-NHS-SS-Biotin
(PIERCE #21331) for 20 minutes at 4°C. Excess biotin was quenched with cold cell
culture media (MEM with serum) and washed 4 times (ice cold PBS-CM). Then the cells
were lysed with RIPA buffer (150 mM NaCl, 50 mM Tris-base, 1% SDS, 0.5% DOC,
pH 8.0) containing protease inhibitors (0.2 M PMSF and 1l/ml protease inhibitor
cocktail set III) for 20 minutes at 4°C. To extract the biotin-labeled cell surface proteins,
50l of streptavidin-agarose slurry (10%) (Pierce #20347D) per 1 ml of cell lysates
were incubated overnight at 4°C with continuous rotation. The streptavidin-agarose-
bound proteins were pelleted, washed 3 times with 1 ml of RIPA buffer, the supernatants
removed, and the remaining pellet suspended in sample reducing buffer. The proteins
were separated by SDS-PAGE and transferred to nitrocellulose membranes. Mock
biotinylated samples were used to control for non-specific binding of proteins to the
streptavidin beads.
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Indirect Fluorescence Analysis (IFA) With Digital Imaging
Biotinylated Samples
The nucleofected BHK-21 cells plated on 10 mm cover slips were used for IFA
analyses in biotinylation or co-localization experiments. After removal of the growth
media and washing with PBS, the cells were biotinylated as indicated above, after which
they were fixed and permeabilized with ice-cold methanol:acetone (1:1), incubated at -
20C for 10 minutes, washed with PBS and blocked with 2% Blotto with rocking
overnight. After blocking, the samples were stained with affinity purified rabbit anti-
NSP4150-175 (1:1000) diluted in 1% blotto for 30 minutes. Following four 10-minute
washes with PBS, the monolayers were treated with goat anti-rabbit Cy2 (1:200 in 1%
blotto) and Steptavidin Cy5 (1:1000 in 1% blotto) to detect the primary antibodies, and
incubated in the dark at RT for 30 minutes with rocking. The cell monolayers were
washed once with PBS (5 minutes), counter stained with Hoechst stain, and washed 4
times with PBS (10 minutes each) in the dark. After washing, the cover slips were air-
dried, mounted inverted on slides using fluorescent mounting media (KPL Inc.) and
sealed with enamel.
NaKATPase Plasma Membrane Marker Samples
To determine the extent to which NSP4 trafficed to the PM, cover slips of BHK
cells prepared as above were probed with rabbit anti-NSP4150-175 (1:1000 in 1% blotto)
and mouse anti-Na/KATPase, a PM marker (1:100 in 1% blotto). The cell monolayers
were washed 4 times (10 minutes each) with PBS, followed by treatment with goat anti-
rabbit IgG-Cy2 (1:250 in 1% blotto)to detect NSP4 antibodies, and goat anti-mouse IgG
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Texas Red (1:100 in 1% blotto) to detect the antibody to the PM, incubated in the dark at
RT for 30 minutes with rocking. The cell monolayers were counter stained Hoechst and
mounted as above.
Epifluorescence
Epifluorescence was used to detect the presence of biotinylated NSP41-175 on the
exofacial leaflet of the PM and colocalization of NSP4 or NSP4 mutants with
NaKATPase. Cells were visualized using a Stallion Digital Imaging Workstation (Carl
Zeiss MicroImaging, Inc., Thornwood, NY) equipped with 300W xenon fluorescent
light source with rapid switching (<2msec) between excitation wavelengths. Images
were collected using a 63X objective 0.75 N.A. a ROPER CoolSnap HQ camera
(Ottobrunn, Germany) and Slidebook 4.2 software (Intelligent Imaging Innovations
(Denver, CO). The Stallion system filter set includes excitation/emission wavelengths
suitable for the color combinations utilized: DAPI and Hoechst (365:445/50 nm), FITC
and Cy2 (470/20:505-530 nm), TX Red and Cy3 (560/40:590 nm) and Cy5 (575-
625/660-710 nm). The images were processed using Image J, which is a public domain,
Java-based image-processing program developed at the National Institutes of Health.
Results
NSP4 Was Exposed on the Exofacial Surface of MDCK Cells Early Post
Infection as Shown by Surface Biotinylation and Western Blot
In our study, the surface expression of NSP4 in RV-infected MDCK cells was
examined at several time points early post infection to determine when NSP4 was first
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exposed on the cell surface. Initial experiments were completed to establish the presence
of NSP4 on the surface of MDCKs at 8 hpi (data not shown). The surface biotinylated
fraction was pulled down with streptavidin coated agarose beads and was examined by
Western blot. In RV-infected MDCK cells, NSP4 was detected on the exofacial surface
only at one time point (7 hpi, Figure 3.1, Panel B, lane 1) prior to 8 hpi with the 4 hpi
time point showing a lack of NSP4 on the exofacial surface (Figure 3.1, Panel A, lane 1).
These data indicate NSP4 reached the cell surface between 4 and 7 hpi in MDCK cells.
We only detected the doubly-glycosylated, 28 kD NSP4 indicating only the fully
glycosylated protein is exposed on the cell surface of these cells (Figure 3.1, Panel B-1).
Figure 3.1. Western blot analyses of surface biotinylated proteins (Panels A and B) . MDCK cells
were infected with RV SA11.4F at a moi of 2 for 4 and 7 hours, surface biotinylated and precipitated with
streptavidin agarose. The cell lysates and precipitated surface proteins were separated by SDS-PAGE and
analyzed by Western blot using anit-NSP4150-175. For the two blots 1 = streptavidin pull down of
biotinylated exofacial proteins, 2 = lysates from biotinylated cells, 3 = streptavidin pull down of mock
biotinylated exofacial proteins, 4 = lysates from no biotin control, 5 = lysates from no RV cell control, 6 =
lysates from RV cell control.
26
17
1 2 3 4 5 6 1 2 3 4 5 6
Panel A: 4 hpi Panel B: 7 hpi
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FLNSP4 Was Exposed on the Exofacial Surface of Transfected BHK Cells
as Shown by Biotinylation Analysis
BHK cells were transfected with FLNSP4 plasmid DNA and examined the
transfected BHK cells at 20 h post transfection for surface expression of FLNSP4 using
surface biotinylation. Our results showed that NSP4 is expressed on the surface of the
BHK cells that have been transfected with FLNSP4. In Figure 3.2, Panel A shows results
for the FLNSP4 transfected cells, panel B shows mock transfected cells, and panel C
shows positive viral (RV SA11.4F) controls. As in RV-infected cells, we only detected
the doubly-glycosylated, 28 kD NSP4 indicating only the fully glycosylated protein was
exposed on the cell surface of these cells. Panel A, lane 2 results verified that FLNSP4
traffics to the PM in the absence of other viral proteins and doubly-glycosylated NSP4 is
exposed on the exofacial surface.
Figure 3.2. Western blot analyses of surface biotinylated proteins (Panels A, B, and C). BHK cells
were mock transfected or transfected with NSP4-FL, surface biotinylated and precipitated with
streptavidin agarose. The cell lysates and precipitated surface proteins were separated by SDS-PAGE and
analyzed by Western blot using anit-NSP4150-175. For the blots 1 = lysates from no biotin control, 2 =
streptavidin pull down of biotinylated exofacial proteins, 3 = lysates from biotinylated cells, 4 = lysates
from RV SA11.4F infected cells.
A. NSP4-FL B. Mock Transfected C. NSP4
1 2 3
26
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1 2 3 4
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FLNSP4Ala Was Exposed on the Exofacial Surface of Transfected BHK Cells While
FLNSP4Hydro Lacked Exposure as Shown by Biotinylation Analysis
To expand this finding, BHK cells were transfected the NSP4 mutant plasmid
DNA (FLNSP4Ala and FLNSP4Hydro) and examined at 20 h post transfection. In
FLNSP4Ala the charged face of the AAH is disrupted with six alanine residues (D114A,
K115A, R119A, E125A, D132A, and K133A), while the hydrophobic face FLNSP4Hydro
was independently disrupted with point mutations at I113R, V124K, and Y131D. As
shown in Figure 3.3, FLNSP4Ala was exposed on the surface of the BHK cells (Panel B,
lane 2), while FLNSP4Hydro was not seen on the cell surface (Panel A, lane2). Taken
together these results indicate that FLNSP4Ala traffics to the cell membrane in the
absence of any other viral proteins. Additionally, the lack of the NSP4-Hydro proteins at
the surface supports the argument that the hydrophobic face of the amphipathic alpha
helix of NSP4 plays a key role in NSP4 trafficing to the cell surface.
Figure 3.3. Western blot analyses of surface biotinylated proteins (Panels A, B, C, and D). BHK cells
were mock transfected or transfected with FLNSP4Ala or FLNSP4Hydro for 20 hrs, surface biotinylated
and precipitated with streptavidin agarose. The cell lysates and precipitated surface proteins were
separated by SDS-PAGE and analyzed by Western blot using anit-NSP4150-175. For the blots 1 = lysates
from no biotin control, 2 = streptavidin pull down of biotinylated exofacial proteins, 3 = lysates from
biotinylated cells, 4 = lysates from RV SA11.4F infected cells.
A. NSP4Hydro B. NSP4Alanine C. Controls D. NSP4
26
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IFA Analysis Confirms That FLNSP4 and FLNSP4Ala Were Exposed on the Exofacial
Surface of Transfected BHK Cells While NSP4Hydro Failed to Traffic to the Cell Surface
Transfected BHK cells were surface biotinylated, or simply fixed and
permerablized and examined by IFA at 20 h post transfection to verify the
biotinylation/Western blot data showing FLNSP4 and FLNSP4Ala localize to the PM and
are exposed on the cell surface, while NSP41-175Hydro does not. The cells were probed
with RbNSP4150-175 followed by gtRb-Cy2 and Streptavidin Cy5 to detect the
biotinylated cell surface proteins or MNa/K-ATPase followed by GtMTXRed to
evaluate colocalization at the PM. As seen in Figures 3.4-3.6, FLNSP4 and FLNSP4Ala
were expressed and exposed on the surface of BHK cells in the absence of viral proteins,
whereas FLNSP4Hydro was not observed at the cell surface.
Figure 3.4. IFA of NSP4-FL biotinylated surface proteins and NSP4-Na/K-ATPase co-localization.
BHK cells were transfected with pcDNA3.2D NSP41-175 plasmid DNA and probed with the indicated
antibodies. Fluorescently tagged secondary antibodies were imaged with 480-nm and then 625-nm
wavelength excitation source to capture Cy2, Texas Red or Cy5 signal. NSP4 (left panels), biotinylated
surface proteins (Panel A, center ), Na/K-ATPase (Panel B, center) distributions are shown. The FLNSP4
colocalizes with biotin at the cell surface (yellow, Panel A, right) and Na/K-ATPase (yellow, Panel B,
right) indicating that it traffics to the cell membrane in the absence of any other viral proteins.
Panel A
Panel B
anti-NSP4 anti-Na/KATPase Co-localization
anti-NSP4 Streptavidin Cy5 Co-localization
gtRb-Cy2
gtM-TXRed
No primary Ab
+ secondary Ab
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These data support the surface biotinylation-western blot analyses. The
biotinylated surface proteins were pseudo-colored red (Figure 3.4, Panel A, center) and
the secondary antibody to NSP4-FL green (Figure 3.4, Panels A and B, left). The images
were merged and co-localized pixels were assessed (yellow, Figure 3.4, Panel A, right).
The presence of co-localized pixels (yellow) indicate that NSP4 is exposed on the cell
surface in the surface-biotinylated samples. This finding is supported by the
colocalization (Figure 3.4, Panel B, right) of NSP4 (green, Figure 3.4, Panel B, left) with
NaKATPase (pseudo-colored red, Figure 3.4, Panel B, center), a plasma membrane
marker.
Figure 3.5 shows FLNSP4Ala-transfected BHK cells (pseudo-colored green, Panel
A, left) as well as total biotinylated surface proteins (pseudo-colored red, Panel A,
center), and the merged image (yellow, Panel A, right), which shows colocalization of
FLNSP4Ala with the surface biotin. These data confirming that FLNSP4Ala had trafficked
to the cell surface in FLNSP4Ala-transfected BHK cells (Figure 3.5, Panel A, left). This
finding is supported by the colocalization of FLNSP4Ala with NaKATPase (Figure 3.5,
Panel B, left), a plasma membrane marker. Hence, FLNSP4Ala trafficked to the PM and
was exposed on the cell surface akin to the WT FLNSP4.
In contrast to the cells transfected with FLNSP4 and FLNSP4Ala, FLNSP4Hydro
failed to traffic to the cell surface (Figure 3.6) as there was no colocalization with the
biotin (Panel A) or with the PM marker (Panel B). Again, these data support the Western
blot analyses.
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Figure 3.5. IFA of biotinylated surface proteins in BKS cells transfected with FLNSP4Ala and FLNSP4Ala
-Na/K-ATPase colocalization. BHK cells were transfected with pcDNA3.2D NSP41-175Ala plasmid DNA and
probed with the indicated antibodies. Fluorescently tagged secondary antibodies were imaged with 480-nm and
then 625-nm wavelength excitation source to capture Cy2, Texas Red or Cy5 signal. NSP41-175Ala (left panels),
biotinylated surface proteins (Panel A, center ), Na/K-ATPase (Panel B, center) distributions are shown. The
FLNSP41-175Ala (green) (Panels A and B) colocalizes with biotin at the cell surface (Panel A, right) and Na/K-
ATPase (Panel B, right) indicating that it traffics to the cell membrane in the absence of any other viral
proteins.
Figure 3.6. IFA of FLNSP4Hydro biotinylated surface proteins, and FLNSP4Hydro-Na/KATPase.
BHK cells were transfected with pcDNA3.2D NSP41-175Hydro plasmid DNA and probed with the indicated
antibodies. Fluorescently tagged secondary antibodies were imaged with 480-nm and then 560-nm or 625-nm
wavelength excitation source to capture Cy2, Texas Red or Cy5 signal. NSP41-175Ala (left panels), biotinylated
surface proteins (Panel A, center ), Na/K-ATPase (Panel B, center) distributions are shown. The FLNSP4Hydro
does not traffic to the cell surface as indicated by the lack of colocalization with biotin at the cell surface
(Panel A, right) or Na/K-ATPase (Panel B, right). These findings support the argument that the hydrophobic
face of the amphipathic alpha helix of NSP4 plays a key role in trafficking NSP4 to the cell surface.
Panel B
anti- NSP4 anti-NaKATPase Co-localization
Panel A
anti-NSP4 Streptavidin-Cy5 Co-localization
anti-NSP4 Na/K-ATPase Co-localization
Panel B
Panel A
anti-NSP4 Strepavidin Cy5 Co-localization
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NSP4 Expression Was Sufficient for Colocalization With Caveolin-1
To determine if viral proteins were required for the intracellular NSP4-caveolin-1
association, epifluorescence was utilized with NSP4-transfected cells. In the absence of
other proteins, transfected NSP4 had similar subcellular distribution patterns in MDCK
and HT29.f8 cells as those observed during RV infection (Figure 3.7, central panels)
(Storey et al., 2007). Both cell lines stained for caveolin-1, whereas only one of the
HT29.f8 cells (of the two shown) was transfected, as indicated by the presence of NSP4
(Figure 3.7, upper panels). Additionally, the NSP4 and caveolin-1 proteins in the
transfected cells colocalized (Figure 3.7, far-right panels) at intracellular sites similar to
those observed in RV-infected cells (Storey et al., 2007), i.e. perinuclear sites, in the
cytosol and at the cell periphery. These results suggest that the NSP4 protein is sufficient
in and of itself to associate with the key caveolar structural protein caveolin-1 in two
different cell types.
Figure 3.7. Colocalization of NSP4 with caveolin-1 in transfected cells. HT29.f8 (top panels) and
MDCK (bottom panels) cells were transfected with pcDNA3.2D NSP4150-175 plasmid DNA and probed with
the indicated primary antibodies. Fluorescently tagged secondary antibodies were imaged with 470-nm
and then 560-nm wavelength excitation source to capture Cy2 and Texas Red signals, respectively (n = 4).
Caveolin-1 (left panels ) and NSP4 (center panels) distributions are shown. Note that only one of the two
HT29.f8 cells shown was transfected (NSP4 signal). The panels on the far right are merged images
showing the colocalization of NSP4 (red) and caveolin-1 (green).
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NSP4 Expression Was Sufficient for Redistribution and Colocalization of the
Caveolin-1 Chaperone Complex Proteins, Cyclophilin A, Cyclophilin 40,
and HSP56 Similar to RV-infected Cells
Epifluorescence was utilized with NSP4-transfected BHK cells to determine if
RV viral proteins were necessary for the association of NSP4 with the proteins of the
Caveolin-1 Chaperone Complex (CCC). Previously, it had been shown that cyclophilin
A, cyclophilin 40, and heat shock protein 56 were redistributed similarly to caveolin-1 in
RV infected cells and the association of these CCC proteins with NSP4 were resolved to
within 10 nm (Gibbons, 2007). Here we use indirect fluorescence analysis (IFA) with
digital imaging to determine if cyclophilin A, cyclophilin 40, and heat shock protein
redistribution is similar to caveolin-1 in transfected cells. BHK cells were transfected
with FLNSP4, fixed, and permerablized and examined by IFA at 20 h post transfection.
The transfected cells were probed with RbCyclophilin A, RbCyclophilin 40, or
RbHSP56, then RbNSP4150-175Cy3 followed by gtRb-Cy2 and Hoechst stain. Figure
3.8 shows the expression of NSP4 (pseudo-colored red, Panels A-C, lane 1) and the
redistribution of the CCC proteins in pseudo-colored green (cyclophilin A, Panel A, lane
2; cyclophilin 40, Panel B lane 2; HSP56, Panel C lane 2). In lane 3 (Figure 3.8, Panels
A-C) the cells have been counter stained with Hoechst stain. Observation of the non-
transfected cells demonstrated that in the absence of t ransfected NSP4, the CCC
proteins were not redistributed. The images from lanes 1 and 2 were merged and co-
localized pixels were assessed (yellow, Figure 3.8, Panels A-C, lane 4). The presence of
co-localized pixels (yellow) indicated NSP4 was colocalized with each CCC protein.
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With each CCC protein the patterns and distributions were similar to the caveolin-1
pattern in the transfected NSP4. IFA results indicate that expression of NSP4 was
sufficient for redistribution of and co-localization with cyclophilin A, cyclophilin 40,
and HSP56 in a similar fashion as in RV-infected cells.
Figure 3.8. NSP4 expression was sufficient for redistribution and colocalization of cyclophilin A,
cyclophilin 40, and HSP56 . The proteins of the caveolin-1 chaperone complex redistribute and co-
localized with transfected NSP4in transfect BHK cells. Each of the proteins of the caveolin-1 chaperone
complex were probed with anti-NSP4 and either anti-cyclophilin A (Panel A), anti-cylcophilin40 (Panel
B), or HSP 56 (Panel C). Redistribution of these proteins occurs in the absence of any other viral proteins.
Discussion
This study examined transfected FLNSP4 and its association with the PM, with
caveolin-1 and the CCC proteins. Additionally, we evaluated whether FLNSP4Ala and
FLNSP4Hydro traffic to the PM and were exposed on the cell surface.
Anti-Cyclophilin 40
anti-NSP4 Anti-Cyclophilin A Hoechst Co-localization
Panel A
Panel B
Panel C
Anti-HSP56
1 2 3 4
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We first examined RV-infected MDCK cells to determine if, when, and what
form of NSP4 is exposed on the exofacial surface of the PM. The results of this study
showed a full-length, endoH-sensitive NSP4 pool was exposed on the exofacial surface
of intact kidney-derived MDCK epithelial cells (7hpi). Several recent reports have
indicated that the NSP4 enterotoxin is secreted from infected cells; however, the form of
NSP4 reported varied. Bugarcic and Taylor (2006) observed secretion of NSP4 by 16
hpi in Caco-2 cells infected with the UK strain of bovine RV at a moi of 10, however the
NSP4 appears post-translationally processed to approximately 32kD with endo H-
resistance. This study reported the 32 kD as predominant form of NSP4 secreted
between 16 and 42 hours post infection. Additionally, the C-terminal NSP4 fragment (aa
112-175) has been isolated from culture medium of baculovirus-gene 10 recombinant
infected Spodoptera frugiperda (SF9) insect cells and RV-infected mammalian cells
(Zhang et al., 2000). Storey et al. (2007) reported that NSP4 traffics to the PM caveolae
of MDCK cells as the doubly glycosylated, endoH-sensitive mature form of the
enterotoxin and is found at the PM at 24 hpi (MOI of 2).
Additionally, caveolae isolated from PM-rich material from RV-infected MDCK
cells yield full-length, high mannose glycosylated NSP4 (Storey et al., 2007). Here we
report that in RV-infected MDCK cells, the same 28kD ‘mature’ form of NSP4 reached
the cell surface between 4 and 7 hpi. Similarly Gibbons (2007) reports PM exofacial
expression of NSP4 at 2-3 hpi in HT29.f8 cells. The detection of NSP4 at early time post
infection is likely prior to release of progeny virus from the cell suggesting that NSP4
does not need infective progeny virus to traffic to from the ER to the PM. These data
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indicate that NSP4 is released from an infected cell well prior to the maturation of the
viral progeny and likely functions in attachment to non-infected cells making them
susceptible to RV-infection.
Our biotinylation data on transfected cells showed that FLNSP4 and FLNSP4Ala
were expressed, localized to the PM, and exposed on the surface of BHK cells in the
absence of other viral proteins, whereas NSP4-Hydro was expressed, but not observed at
the cell surface. The lack of cell surface exposure of transfected FLNSP4Hydro is likely not
related to the absence of other viral proteins, but could be due to the lack of ability of
FLNSP4Hydro to bind caveolin-1. In FLNSP4Ala the charged face of the amphipathic alpha
helical (AAH) is altered with six alanine residues (D114A, K115A, R119A, E125A,
D132A, and K133A), while the hydrophobic face was unaltered. FLNSP4Hydro was
disrupted with point mutations at I113R, V124K, and Y131D in the hydrophobic face and
the charged face was unaltered (Figure 2.3). Previously, we have shown by yeast two-
hybrid that the NSP4-caveolin-1 binding domain was localized to one critical
hydrophobic aa (L116) and one or two additional aa (I113, L127, and/or L134) on the
hydrophobic face. FLNSP4Ala retained binding to caveolin-1, while FLNSP4Hydro lacked
binding with caveolin-1. Taken together the failure of FLNSP4Hydro to traffic to the cell
surface or co-localization with the PM marker and its lack caveolin-1 binding suggest the
interaction of NSP4 and caveolin-1 contribute to the transport of the enterotoxin to the
cell surface. This supports the argument that the hydrophobic face of the AAh of NSP4
plays a key role in trafficking NSP4 to the cell surface and supports the thesis of Parr et
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al. (2006) suggesting the NSP4-caveolin-1 association contributes to NSP4 intracellular
trafficking from the ER to the cell surface.
Epifluorescence was utilized with NSP4-transfected cells to determine if other
viral proteins were required for the intracellular NSP4-caveolin-1 association, NSP4 and
caveolin-1 have been shown to co-localize at multiple sites within RV-infected cells
(Berkova et al., 2006; Parr et al., 2006; Storey et al., 2007). A comparison of the NSP4
transfected MDCK and HT29.f8 in the absence of other viral proteins with RV-infected
NSP4 localization (Storey et al., 2007) shows a similar subcellular distribution pattern.
Additionally, compared with RV-infected cells, the NSP4 and caveolin-1 proteins in the
transfected cells colocalized at intracellular sites similar to those observed in RV-
infected cells (Storey et al., 1007).
NSP4 expression was sufficient for redistribution and colocalization of the CCC
proteins, cyclophilin A, cyclophilin 40, and HSP56 similar to caveolin-1 as shown by
IFA. These data suggest that in the absence of viral other proteins, some portion of NSP4
associates with the CCC. Additionally, these data support the findings that CCC proteins
are redistributed during RV infection by NSP4 and the association of these CCC proteins
with NSP4 has been resolved to within 10 nm (Gibbons, 2007). However, neither PCR
nor western blot data showed an increase in messenger RNA for the CCC proteins
(Gibbons, 2007) suggesting the CCC proteins are only redistributed and not upregulated.
Silencing NSP4 has shown no marked effect on the expression of other viral proteins or
on the replication of the dsRNA genome segments (Silvestri et al., 2005); however,
blocking the synthesis of NSP4 suppressed viroplasm maturation and affected the
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intracellular accumulation and the cellular distribution of several viral proteins (Lopez et
al., 2005b). These data plus the fact that NSP4 bypasses the Golgi apparatus (Storey et
al., 2007) and our data on NSP4-caveolin-1 and the CCC suggest that NSP4 may
preferentially traffic using the soluble complex pathway.
The data presented here suggests NSP4 expression alone is sufficient to carry out
its functions. It traffics from the ER to PM, co-localizes with caveolin-1, and
redistributes the CCC protrins in the absence of other viral proteins. NSP4 may use the
CCC and the soluble complex pathway for the trafficking to various regions of the cell
including the viroplasm and the PM. Additional studies are needed to fully understand
the pathway of NSP4 to the PM.
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CHAPTER IV
CONCLUSION AND FUTURE DIRECTIONS
Overview
The purpose of this research was to identify the region or regions of the NSP4 C-
terminal amphipathic alpha helix (AAH) that are sufficient for binding caveolin-1. Using
the WT NSP4 and a panel of nine NSP4 mutants in yeast two hybrid (Y2H) assays, the
NSP4 caveolin-1 binding domain was localized to one critical hydrophobic aa (L116)
and two additional aa on the hydrophobic face. Those mutants that bound caveolin-1
bound both the N- and C-terminal caveolin-1 peptides in peptide binding assays, but
lacked binding to a centrally located peptide, which verifies earlier results that WT
NSP4 binds to both the N- and C- termini of caveolin-1 (Mir et al., 2007).
Additional studies determined that in the absence of other viral proteins,
transfected FLNSP4 colocalized with caveolin-1, trafficked similarly to NSP4 in RV-
infected cells, and appeared to redistribute and colocalize with the caveolin-1 chaperone
complex proteins (Figure 3.8) as seen in RV-infected cells. These results confirm similar
results from RV-infected cells and that the expression of the toxin is sufficient in and of
itself to cause these effects.
Rotavirus NSP4 Binds Caveolin-1 on the Hydrophobic Face of the
Extended Amphipathic Alpha Helix
To dissect the precise NSP4 binding domain to caveolin-1, NSP4 mutants were
prepared by altering either the charged (FLNSP4Ala) or hydrophobic face
(FLNSP4Hydromut) of the NSP4 C-terminal AAH and examined for binding to caveolin-1.
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Initially, we demonstrated that the hydrophobic face of the NSP4 AAH binds caveolin-1
since binding was abolished with the FLNSP4Hydromut in which three hydrophobic
residues were replaced with charged amino acids (aa). This suggested that the
hydrophobic face of the NSP4 AAH binds caveolin-1 via a hydrophobic interaction.
Mutants of FLNSP4Hydromut in which one of the three mutated aa residues was reverted to
the original hydrophobic residue regained binding to caveolin-1, which led to our
hypothesis that a minimum of three hydrophobic residues in the C-terminal hydrophobic
face of the NSP4 AAH are required for binding caveolin-1. Additional alanine mutants
were used to support our hypothesis, indicating that L116 and at least two additional
hydrophobic residues were sufficient to facilitate NSP4 binding to caveolin-1. A
potential binding motif of113L116124127131134 (is hydrophobic,is aromatic, and L
is leucine) has been identified, which lies in two distinct planes of the NSP4
hydrophobic face of the AAH. From our data we propose that three hydrophobic aa are
needed for NSP4 to bind to caveolin-1 and at least two hydrophobic residue must reside
in the plane containing L116 and at least one hydrophobic residue must reside in the
other plane.
Rotavirus NSP4 Is Expressed and Trafficked in the Absence of Other Viral Proteins
The purpose of this research was to determine the effect of the absence of RV
replication and other RV proteins on the expression and transport of NSP4 in transfected
cells. We utilized FLNSP4, FLNSP4Ala and FLNSP4Hydro to transfect BHK cells. Our
results revealed only FLNSP4 and FLNSP4Ala were expressed and exposed on the
surface of BHK cells (by surface biotinylation) in the absence of other viral proteins.
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While FLNSP4Hydro is expressed in transfected BKK cells, it was not exposed on the
surface of BHK cells. In light of our previous finding that FLNSP4Hydro does not bind
caveolin-1 and NSP4 has been shown in PM caveolae (Storey et al., 2007), the
association NSP4 with caveolin-1 may contribute to the toxin’s intracellular trafficking
(Parr et al., 2006). Additional data are needed to confirm these observations.
In addition, epifluorescence was used to demonstrate that in transfected cells,
FLNSP4 colocalizes with caveolin-1 similar to that observed in RV-infected cells. The
data suggested that expression of NSP4 without other RV proteins does not hinder its
intracellular transport or its interaction with caveolin-1. Moreover, NSP4 expression was
sufficient for an apparent redistribution and the colocalization with the caveolin-1
chaperone complex proteins, cyclophilin A, cyclophilin 40, and HSP56 similar to that
seen in RV-infected cells.
Advances and Significance
This research adds to the body of knowledge on RV NSP4 in that it specifically
(a) verified that the NSP4 to caveolin-1 binding domain is in the hydrophobic face of the
AAH and that the interaction is hydrophobic in nature; (b) established the NSP4-
caveolin-1 interaction is specific in requiring L116 and two additional hydrophobic
residues that possibly form a ‘pocket’ through which the caveolin-1 binding occurs; (c)
determined that at least one hydrophobic residue must be present in each of two planes of
the hydrophobic face in addition to the L116 for NSP4-caveolin-1 interaction to occur;
(d) transfection of NSP4 showed that it interacts with caveolin-1 in the absence of other
viral proteins; (e) supported the hypothesis that NSP4 may use the caveolin-1 interaction
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to traffic to the PM as the both FLNSP4 and FLNSP4Ala were found on the exofacial of
BHK cells; and (vi) showed an apparent redistribution of the CCC complex proteins by
NSP4 in the absence of RV viral proteins similar to that observed in RV-infected cells.
The data on the NSP4-caveolin-1 interaction of the hydrophobic mutants suggest
that not only are hydrophobic constraints, but also conformational constraints, may play a
role in the NSP4-caveolin-1 association. For example, the Rev2 M116A mutant has
hydrophobic residues in both planes of the hydrophobic face of the AAH, but lacks L116,
thus fails to bind, supporting the requirement specific hydrophobic residue at the aa
position116. Also, the binding NSP4 may be conformational specific as the Hydromut
mutant, which does not bind caveolin-1, contains the critical aa L116 and hydrophobic
residues L127 and L134, but lacks a hydrophobic residue in one plane of the hydrophobic
AAH. This suggests the hydrophobic face of the AAH is more severely disrupted than in
the revertants, which differ from Hydromut only by possessing hydrophobic residues in
both planes. This disruption may be due to conformational changes caused by the
presence of the charged residues (Couet et al., 1997a). The hydrophobic face appears to
be able accommodate for the absence of some of the aas and continues to bind caveolin-
1. Another possible outcome of the two planes hypothesis may be that the N-terminus
binds one plane, while the C-terminus binds the other plane. This remains to be
determined.
The definitive results of the Y2H analyses led to follow-on transfection studies to
verify the association of NSP4 with caveolin-1 in absence of other viral proteins. The
results of the transfections studies showed that FLNSP4 and FLNSP4Ala, but not
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FLNSP4Hydro were expressed and exposed on the surface of BHK cells in the absence of
other viral proteins. Additionally, IFA studies showed the NSP4 protein is sufficient in
and of itself to associate with the key caveolar structural protein caveolin-1 and is
apparently sufficient for redistribution and colocalization of the CCC proteins,
cyclophilin A, cyclophilin 40, and HSP56 similar to caveolin-1. These results confirm
similar results from RV-infected cells. The expression of the toxin is sufficient to cause
these effects. These data coupled with the Y2H binding data suggest that NSP4 uses
caveolin-1 to traffic within the cell and adds support to the thesis that the toxin may use
the CCC to transport from the ER to the PM allowing NSP4 to avoid Golgi glycosylases
(Parr et al., 2006).
The data on the lack of association FLNSP4Hydro with caveolin-1 and its lack of
transport to the PM might be useful in the development of a RV vaccine and/or drug
therapy. A structure-function study could be conducted to determine if a RV mutant
containing FLNSP4Hydro has a different or less severe pathology than wild type RV. This
mutant could be used to generate a vaccine that does not have the potential side effect of
causing diarrhea. Alternatively, drug therapy to treat RV infection could be developed
that specifically targets the hydrophobic region of the AAH of NSP4. The drug treatment
would have to out compete caveolin-1 for the hydrophobic AAH binding site.
87
Strengths, Weaknesses, and Resolutions
Yeast-Two-Hybrid
The Proquest yeast two-hybrid system (Invitrogen, Carlsbad, CA) is a well-tested
technology for detecting protein-protein interactions in vivo and adds strength and
validity to this study. Proquest system uses three reporter genes to minimize false
positives. Additionally, a panel of five controls that display a spectrum of protein
interactions allow for assessment of test colony phenotypes resulting from the interaction
of the proteins of interest. However the expression of NSP4 and caveolin-1 as the GAL4
fusion proteins may present some difficulties. The fusion proteins may not fold in a
manner similar to the wt protein, which might result in steric hindrance of the binding
domain and thus abrogating binding. We resolved this weakness by assaying a large
number of colonies (90+) and confirming our Y2H results with peptide binding and
western blot assays.
Yeast systems use different glycosylation enzymes that may result in different
glycosylation patterns in the proteins of interest. In yeast N-linked glycosylation consists
of as many as 50 mannose residues. This is a concern with NSP4 as it contains two N-
linked glycosylation sites (Estes and Cohen, 1989). Alternative glycosylation or
hyperglycosylation could affect protein folding and stabilization, and consequently
binding. This issue was resolved by determining the glycosylation pattern on NSP4
mutants expressed in yeast by Endo H digestion. The glycosylation of FLNSP4Hydromut in
yeast was equivalent to that observed in mammalian cells.
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Transfection Studies
Toxic effects of NSP4 on cells made this protein difficult to transfect. The use of
electroporation or chemical transfection (Lipofectamine™2000) was difficult and
inconsistent. The numbers of transfected cells was extremely low (e.g., one or two cells
in a field of view at 600X). Use of nucleofection did improve transfection efficiency. The
use of an inducible system (e.g., Clontech’s Tet-On Advanced and Tet-Off Advanced
Inducible Gene Expression Systems) could be used to increase transfection efficiency.
Also, transfection of intestinal cell lines (HT29.f8) proved to be especially difficult. As a
result, BHK cells were used in transfection studies, which may lead to questions of
validity of extrapolating results to intestinal cells. However, we did show that in the
absence of other proteins, transfected NSP4 had similar subcellular distribution patterns
in HT29.f8 cells as those observed during RV infection.
NSP4-Caveolin-1 Binding Site
A weakness of the current study is that NSP4-caveolin-1 binding site was not
unequivocally identified. While this study has localized the NSP4-caveolin-1 binding site
to L116 and two additional hydrophobic residues in each of two planes of the
hydrophobic face, it did not establish: (a) if aa leucine at the 116 position is required or if
any hydrophobic aa is sufficient for binding or (b) if L116/116 position alone is the
binding ‘site.’ Also, the study did not determine whether the N- and the C-termini of
caveolin bind at the same binding site.
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Colocalization Does Not Mean Interaction
The colocalization of transfected NSP4 and caveolin-1 or PM markers resolved
the proteins to about 200 nm. Moreover, since the PM is about 5 nm in width,
colocalizing NSP4 with the PM only locates to within a 200 nm region of the PM. This
only indicates that the proteins closely approach each other and may not in fact interact.
Fluorescent Resonance Energy Transfer (FRET) is a more definitive technique to
verify protein-protein interaction. FRET is a process in which nonradiative energy
transfer occurs from one fluorophore to another when the two fluorophores (e.g.,
fluorescently tagged proteins) are within 10 nm of each other (Kenworthy, 2001). The
use of acceptor photobleaching, a process in which the acceptor fluorophore is bleached
and an increase in fluorescence of the donor fluorophore is monitored, is useful to
determine if the two proteins interact (Karpova et al., 2003). The purpose of the
colocalization studies was to determine if transfected NSP4, in the absence of other viral
proteins, traffics similarly to NSP4 expressed in infected cells. FRET analyses
established that NSP4-caveolin-1 and the immunophilin proteins associate to within 10
nm in RV-infected cells and that the toxin is expressed on the exofacial leaflet of the PM.
A future aim will be to evaluate the NSP4 mutants association with caveolin-1 and the
immunophilin proteins.
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Future Research
Unequivocal Delineation of the NSP4 Caveolin-1 Binding Site
Since the NSP4 binding domain was not precisely delineated, additional mutated
NSP4 peptides of the AAH region, could specifically map the aa residues required for
binding. The peptides would be used in direct fluorescence binding assays and/or peptide
binding assays with N- and C-caveolin-1 peptides to assess NSP4-caveolin-1 interaction.
Both the N- and C-caveolin-1 peptides would be used in these studies to determine if
both termini bind to the same NSP4 binding site. The NSP4113-135 used as a positive
control and the NSP4HydroMut peptide would be used as a negative control. Peptides
NSP4113-135, L116A and NSP4113-135, L134A would determine if L116 is required for binding
and resolve the importance of L134 in binding. A peptide mutating I113, V124, L127,
Y131, and L134 to alanine residues and retaining only the L116 would definitively
resolve its importance in caveolin-1 binding. If this peptide binds caveolin-1, the L116
could be replaced with another hydrophobic molecule to determine if leucine is
specifically required for binding.
Peptide NSP4113-135, I113A, V127A, Y131A , the alanine analog of NSP4Hydromut, would be
used to establish the importance of conformation in the binding to caveolin-1. Recall that
NSP4Hydromut contains one of the possible hydrophobic binding face (L116, L127, L134)
identified in this study, but does not bind. Binding of alanine analog of mutant of
NSP4Hydromut would confirm the importance of conformation, as well as support that
L116, L127, L134 is a possible hydrophobic binding face.
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Structural analyses using Circular Dichroism (CD) spectroscopy could be
conducted to determine the structural consequences of the mutations. Yeast-two-hybrid
would be used to verify positive interaction in vivo.
Role of the Immunophilins in NSP4 Trafficking to the PM
The focus of our research group is on the intracellular transport of NSP4 and the
mechanism(s) by which it occurs. Not only have we shown that NSP4 traffics to the PM
(Gibbons, 2007), but we also have shown that NSP4 associates with caveolin-1 and
apparently redistributes the cytosolic immunophilin proteins, cyclophilin A, cyclophilin
40, and HSP 56 (Gibbons, 2007; Chapter III this work). The caveolin-1 and the
immumophilins deliver newly synthesized cholesterol to PM caveolae. Given that NSP4
localizes to the PM caveolae, binds caveolin-1, and redistributes the immumophilin
proteins, the immumophilins may function to deliver NSP4 to the PM as well. The
following approach could be used to investigate the immumophilin’s role in NSP4
trafficking to the PM: (a) screen for individual immunophilin protein interaction with
NSP4 mutants using fluorescence binding assays; (b) map the NSP4 binding site of
immunophilin proteins with positive fluorescence binding assays using yeast two-hybrid;
and (c) determine structure-function impact of immunophilin protein deficiency. A brief
description of the studies is given below.
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Determine if Immunophilin Proteins Interact With NSP4 Mutants Peptides
Using Fluorescence Binding Assays
Direct fluorescent binding assays could be used to screen for direct binding of the
NSP4 mutants with each immunophilin protein (Hostetler et al., 2005) to FLNSP4 would
be expressed in yeast and affinity purified, peptides NSP4 113-135Alanine, NSP4113-135Hydromut,
and other selected NSP4 peptides can be made in our laboratory, while the immunophilin
proteins are commercially available. The immunophilin proteins would be directly
labeled with a Cy3 fluorescent dye and titrated with the NSP4 protein to demonstrate a
direct protein-protein interaction. Initially the Cy3-labeled immunophilin protein is in a
hydrophilic environment and the fluorescence is quenched, however upon titration with a
binding protein/peptide, such as FLNSP4, places the Cy3 molecule in a hydrophobic
environment abrogating the quenching of the Cy3 fluorescence. This results in an
increase in fluorescence intensity suggesting that the two proteins or protein/peptide
interact. If the titrating protein/peptide does not bind the Cy3-labeled immunophilin
protein, no change in fluorescence intensity is detected. Binding to FLNSP4 only or
binding FLNSP4, FLNSP4Alanine, and FLNSP4Hydromut suggests that the binding is not in
the AAH region. Binding to FLNSP4 and either FLNSP4Alanine or FLNSP4Hydromut
indicates that binding is in the AAH region. If binding is not in the AAH region, a series
NSP4 deletion peptides (e.g. NSP41-107, NSP445-175, NSP4112-175, NSP4135-175, and NSP490-
150) could be made localize the binding site(s) of the immunophilins.
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Confirm the NSP4 Binding Site of Each of the Immunophilin Proteins Using Our
Panel of NSP4 Mutants in Yeast-two-Hybrid
Using the immunophilin proteins that have been shown to interact with NSP4
mutant peptides, we would use yeast two-hybrid as above to map the binding domains
within NSP4 in vivo. We have both the NSP446-175 activating domain (AD, pDest22 AD-
NSP446-175) and binding domain (BD, pDest 32 BD- NSP446-175) fusion proteins. The AD
and BD fusion proteins for the immunophilin proteins could be prepared using
commercially available clones (Ultimate™ ORF, Invitrogen) and subcloned into the
Invitrogen Gateway™ Destination vectors pDEST22 and pDEST32 as previously
described (Parr et al., 2006; Zhou et al., 2004) Expression of fusion proteins will be
verified with Western blot and appropriate antibodies. A series of yeast transformation
(forward and reverse) as describe earlier would be conducted to detect protein-protein
associations between NSP4 and the individual immunophilins proteins. Transcription
activation will be restored only if the AD fusion protein and BD fusion protein interact,
resulting in the expression of the reporter genes. Interaction of caveolin-1 with NSP446-175
will be used as a positive control and the lack interaction between caveolin-1 with
NSP4Hydromut will be used as a negative control. Our first screen would be with NSP4Ala ,
NSP4HydroMut, and a new mutant NSP4Ala-HydroMut (alanine analog of Hydromut) with each
immunophilin protein. Follow-on testing would depend upon the binding pattern. If the
interaction is with the hydrophobic face (binds NSP4Ala , but not NSP4HydroMut or NSP4Ala-
HydroMut), we would use our existing panel of hydrophobic mutants to map the binding
domains of the immunophilin proteins. If the interactions occur with the polar face (binds
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NSP4HydroMut and NSP4Ala-HydroMut, but not NSP4Ala) a new set of polar face mutants will
have to be designed, generated and used to map binding site(s). If the immunophilin
proteins bind NSP4Ala , NSP4HydroMut, and NSP4Ala-HydroMut, this would indicate that the
binding site is outside the AAH, consequently we would used our panel of NSP4 deletion
mutants to map the binding domains.
Verify NSP4 Interaction With Immunophilin Proteins by Peptide Binding Assays
Once the putative binding domains have been identified, peptide binding assays
could be used to verify direct binding of the NSP4 peptide with each immunophilin. The
NSP4 peptides containing the putative immunophilin protein binding domains would be
prepared and attached to CNBr-activated sepharose 4B beads and incubated overnight at
4ºC with the commercially obtained immunophilin. The beads were washed as previously
described and resuspended in SDS-PAGE loading buffer. The proteins would be
separated on 12% SDS-PAGE, transferred to nitrocellulose membranes and probed with
immunophilin- or NSP4-specific antibodies in a Western blot assay.
Determine Structure-Function Impact of Cyclophilin A Protein Deficiency
A Cyclophilin A negative cell line has been developed by homologous
recombination (Braaten and Luban, 2001) and used to study its function in regulation
HIV-1 infectivity. This cell line could be similarly used to assess the impact of the lack of
cyclophilin A on the transport of NSP4 via the caveolin-1 and the immunophin.
Cyclophilin A deficient mice (Colgan et al., 2004) could be used in structure-
function studies to determine if NSP4 produces diarrhea in the absence of this
immunophilin. A DD50 response curve using RV SA11 would be determined in non-
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deficient mice (Ball et al., 1996), which would be used to infect the cyclophilin A
deficient mice. Production of diarrhea would indicate that the lack of cyclophilin A does
not impair ability of NSP4 to produce its toxic effect, while the lack of diarrhea
production would indicate a functional role for cyclophilin A.
Use of Quantum Dots
A quantum dot (QD) is a semiconductor whose excitons (electron-hole pair) are
confined in three spatial directions. The bound electron-hole pairs provide a means to
transport energy without transporting net charge. QDs have an interesting optical
property that results in QDs of the same material, but different sizes emitting light of
different colors. QDs are typically 5-15 nm in size. The larger QDs contain more energy
levels more closely spaced, therefore can absorb photons of lower energy (longer
wavelength) resulting in emission in the red region. Conversely, the smaller the QD the
higher the energy of the photons absorbed resulting in blue emission. This “tenability”
has allowed for the development of QDs with a common excitation profile, but different
fluorescent emission maxima. QD antibody conjugation kits are available in seven (7)
different fluorescent colors.
Develop a Methodology to Create a “Model Caveolin-1 CCC”
Similar Model Membranes
Apparently, the work of Uittenbogaard et al. (1998) and Uittenbogaard and Smart
(2000) on the “caveolin-1 chaperone complex” has not been duplicated. They suggest
that the CCC does not form in the absence of caveolin-1. It might be possible to fabricate
“model CCC” using techniques similar to those used to make model membranes in the
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presence and absence of caveolin-1. The commercially available components could be
(CCC proteins, caveolin-1, and cholesterol) could be fluorescently tagged (possibly with
Quantum dots) for use in hyperspectral imaging confocal microscopy (capable of
separation of up to eight flurophores) to confirm the model caveolin-1 CCC. If it is
possible to make the model Caveolin-1 CCC it would be used to verify NSP4 interaction.
Use of Quantum Dots to Determine the Formation of the Caveolin-1 Chaperone
Complex (CCC) In Vivo
The CCC does not form in caveolin-1 negative cells (i.e. L1210-JF). This cell line
could be then transfected with YFP-labeled caveolin-1 followed by treatment with the
CCC protein QD-labeled antibodies to demonstrate the formation of the CCC. Treatment
of the caveolin-1 null cells with the CCC protein QD-labeled antibodies would
demonstrate the lack of formation of the CCC. The QDs could be visualized with
hyperspectral imaging confocal microscopy (capable of separation of up to eight
flurophores).
Use of Quantum Dots to Determine Interaction of NSP4 With CCC
If the CCC can be demonstrated, follow-on research could be conducted using
L1210-JF transfected with GFP-labeled NSP4 and YFP-labeled caveolin-1 followed by
treatment with the CCC protein QD-labeled antibodies to demonstrate the colocalization
of NSP4 with caveolin-1 and the CCC. The samples could be visualized with
hyperspectral imaging confocal microscopy.
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Use of Quantum Dots to Track Externally Added NSP4 Attachment and Internalization
Seo et al. (2008) have demonstrated that integrin11 and 21 are receptors for
NSP4. Observation of the attachment of NSP4 to these receptors and its internalization
cold be monitored in lives cells using quantum dots (QDs). A cell line (BHK) could be
QD-labeled11 and21 (Invitrogen Qdot ITK) followed by treatment with GFP-
NSP4 enterotoxic peptide. Confocal and Total internal reflection fluorescence (TIRF)
microscopy could be used to monitor in real-time the attachment and possible
internalization of the labeled NSP4 (or NSP4 enterotoxic peptide).
Verification of Model NSP4 Binding Caveolin-1 and Caveolae Lipids
We have proposed a model whereby NSP4 binds to caveolin-1 protein and
caveolae lipids on opposite faces of the C-terminal AAH, which facilitates its crossing
the PM. It has been shown that NSP4 binds unilamellar vesicles (SUVs), but the binding
site has not been delinated. We know NSP4 binds caveolin-1 on the hydrophobic face of
the NSP4 AAH and suggest that it binds unilamellar vesicles (SUVs) on the polar face.
This model could be verified by fluorescence binding assays with small unilamellar
vesicles (SUVs) with NSP4113-135 Alanine and NSP4113-135 HydroMut mutant peptides. A
positive fluorescence binding assay with NSP4113-135 HydroMut and a negative fluorescence
binding assay with NSP4113-135Alanine would support binding of NSP4 to the SUVs on the
polar face of the NSP4 AAH. In vivo mammalian cell studies in which the cells have
been treated with fluorescently tagged phospholipids (e.g., Cy5) and infected with RV or
transfected with NSP4 could be used to verify the model. The NSP4 and caveolin-1 are
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visualized with fluorescent antibodies (Cy 2 and Cy3). If colocalization occurs among the
lipids and the two proteins, FRET analyses could be conducted to confirm possible
interaction. A caveolin-1 deficient cell line (L1210-JF) could be used to determine if
NSP4 binds other caveolae lipids in the absence of caveolin-1.
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